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Organometallic complexes have long been employed as therapeutic agents in 
the diverse field of biomedical sciences. In this thesis, the use of 
organometallic complexes as anti-cancer drugs, as cell signaling molecules 
and as thiol sensors are explored. In Chapter 1, a brief introduction to the 
chemistry of organometallic and transition metal complexes along with the 
objectives of this work are described. The variable oxidation states exhibited 
by transition metals allows for a huge myriad of derivatives to be synthesized 
and used for the different biomedical applications listed above. In addition, the 
presence of carbonyl ligands in the molecule facilitates the characterization of 
the newly synthesized complexes. Representative examples of transition metal 
complexes well-studied in the field of anti-cancer, cell signaling and thiol 
sensing are then listed and their pros and cons discussed. 
In Chapter 2, the synthesis and use of CpFe(CO)2X as possible cytotoxic 
agents towards breast (MDA-MB-231) and HeLa adenocarcinoma cells were 
investigated. The MTT assays have shown that these CpFe(CO)2X class of 
complexes are effective against both the breast and HeLa cell lines with 
CpFe(CO)2I performing the best with IC50 of 3.7 M. Confocal and flow 
cytometry data also support the data obtained from cytotoxicity assays. 
Previous studies have shown that organic isothiocyanates such as sulforaphane, 
benzyl isothiocyanate and phenethyl isothiocyanate inhibit the growth of 
breast cancer cells, but have undesirable effects on normal mammary cells. It 




cyclopentadienyl iron dicarbonyl [CpFe(CO)2] complexes, the toxicity 
towards normal cells can be mitigated.  
Chapter 3 investigates the cytotoxic properties of other metals complexes such 
as those of manganese and cobalt in the treatment of breast and cervical cancer. 
The results are not as promising as the CpFe derivatives with the cobalt 
complexes inactive towards the breast cancer cells. The manganese complexes 
on the other hand were too toxic towards the normal mammary cells to be of 
any practical use. The effectiveness of other iron-containing complexes 
without the cyclopentadienyl (Cp) ring on causing cell death in both breast and 
cervical adenocarcinoma was also evaluated, compared and discussed with 
reference to the cytotoxicity data obtained from Chapter 2. In addition, the 
potency and efficacy of organic isothiocyanates as anti-carcinogenic agents 
from initial studies will be discussed as well. 
Chapter 4 discusses the role of gasotransmitters such as H2S and CO in our 
body. First of all, an iron carbonyl complex carrying a thiocarboyxlic acid 
ligand was synthesized. The resulting complex is water soluble, and air and 
light stable. Not only that, irradiation under UV-vis radiation released the CO 
within an hour. H2S release was achieved from a series of Group 6 transition 
metal carbonyl hydrosulfides. These release H2S slowly over an hour upon 
hydrolysis in water. Cytotoxicity tests performed on these releasing molecules 
have shown that they are benign towards normal mammary cells. The ability 
to release these gaseous small molecules from metal carbonyl complexes 
allows them to find applications in diverse conditions involving blood vessel 




Besides anti-cancer treatment and gas release, organometallic complexes can 
also be used in the sensing of thiols, an important class of naturally occurring 
organic molecules whose levels in the body have been shown to be implicated 
in a variety of ailments such as Alzheimer’s cancer and cardiovascular disease. 
This will be discussed in Chapter 5, where an investigative study of using 
CpMn(CO)2 radical that can function as a thiol sensing molecule was carried 
out. Aromatic and aliphatic thiols induce different colour changes which were 
characterized by UV-vis and infrared spectroscopy. Further functionalization 
by CO substitution was also performed which enable the differentiation 
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The first use of organometallic complexes in the study of biological systems 
began in 1985 and it saw the birth of the term ‘bioorganometallic chemistry’ 
[1, 2]. This idea of bringing together two different disciplines  chemistry and 
biology  has of course been proposed before by many researchers, each 
opening up a new field of bioorganometallic research. This multidisciplinary 
nature of this new area has subsequently led to the development of 
organometallic complexes for a broad variety of biomedical applications. 
Some of the biomedical applications arising from the advancement of 
bioorganometallic chemistry research are anti-cancer [3-5], 
radiopharmaceuticals [6, 7], gasotransmitters releasing molecules [8-14], 





20], genosensors [21-23], models for bioorganometallic reaction centres [24-
28] and supramolecular host processes [29, 30]. For the scope of this thesis, 
we shall focus on three areas, namely, anti-cancer to be discussed in Chapter 2 
and 3, CO- and H2S- releasing molecules in Chapter 4 and in Chapter 5 we 
will examine how a manganese based complex can be used as a probe for 
sensing of biomolecules molecules. 
1.1 Organometallic Compounds as Anti-Cancer Agents 
One of the first carcinogens discovered and identified in 1930 is a class of 
compounds known as polycyclic aromatic hydrocarbons [31] and thereafter it 
sparked off a multi-million dollar research industry whose mission is to 
identify the cause and to develop strategies for the prevention, diagnosis and 
treatment of cancer. Today, even though that goal has remained the same, 
cancer is no longer regarded as a single disease but rather a collection of more 
than 200 types of ailments that can affect potentially every single organ in the 
human body [32]. Due to this diverse cancer typing, survival rates are highly 
variable and are dependent upon the type and stage of the tumour growth. For 
instance, patients with testicular cancer, prostate cancer, melanoma and 
Hodgkin lymphoma typically have a 10-year survival rate of 80% but for 
patients suffering from pancreas, lung, stomach, oesophagus and brain cancer, 
the 10-year survival rate plummets to a dismal 15% [33]. Evidently, while we 
have achieved numerous breakthroughs in cancer biology over the last five 
decades, this molecular knowledge and new information have not led to a 
significant improvement in cancer mortality. This is in part due to the fact that 
of all the potential drug candidates that research churns out, only a depressing 





20% of cardiovascular drugs that have undergone clinical trials are now 
commercially available [34]. Not only that, the huge diversity of cancer types 
has made it perplexing to translate the new research knowledge into cures. 
Cancer research thus must press on so that these new discoveries can be made 
that improve the way we prevent, diagnose and treat cancer.  
1.1.1 Use of Carbonyl Complexes in Treatment of Cancer 
Currently, chemotherapy remains the most common type of treatment that 
cancer patients undergo although it is usually in combination with surgery 
and/or radiotherapy. While cytotoxic platinum drugs (cisplatin, carboplatin 
and oxaliplatin) are still used in more than 50% of the treatment regimens 
during chemotherapy [35], there is still a need to sought out alternative drugs 
that can effectively curb the proliferation of cancer tumours due to the 
emergence of platinum resistance and severe side effects associated with 
current platinum-based therapeutics such as neuro-, hepato- and 
nephrotoxicity [36]. Such limitations imposed by platinum-based drugs 
(Figure 1.1) have prompted chemists to look to the use of other transition 
metals in the development of anti-cancer drugs. In particular, organometallic 
complexes (compounds containing at least a single metal-carbon bond) 
containing ruthenium and osmium have shown to be extremely promising drug 
candidates and hence are among the most widely studied non-platinum drugs 
for anti-cancer therapy [37-41]. Other popular organometallic complexes 
(Figure 1.2) that have also demonstrated inhibitory properties towards cancer 
cells proliferation include organic compounds with organometallic 





[48-52] and metallocenyls [53] have also been documented to show in vitro 
metal-based anticancer activity. 
 
Figure 1.1 Selected examples of platinum based drugs commonly used in 
chemotherapy. 
 





Organometallic complexes offers many unique properties not found in 
classical organic compounds. Structurally, they can adopt a huge variety of 
shapes ranging from linear to octahedral and even beyond. This structural 
assortment allows chemists ample opportunities to easily modify the 
stereochemistry of an organometallic complex. For example, a carbon atom 
with four different substituents can only exist as two different stereoisomers. 
In contrast, a metal ion surrounded by 6 different ligands has a total of 30 
stereoisomers! Not only that, because of the d-orbitals possessed by metal ions, 
they can adopt a variety of geometries whereas carbon can adopt only planar 
and tetrahedral geometries (Figure 1.3). These unique properties of metal 
complexes, coupled with rational ligand design, allow chemists to come up 
with novel ways to circumvent the limitations of current cancer treatment 
methodology. 
 





As of today, osmium and ruthenium complexes have been extensively 
researched and their cytotoxic and biological properties are now well-
documented [3-5, 45, 46, 54-58]. However, the use of transition metal 
carbonyl complexes in the pursuit of alternative anti-cancer drugs have not 
received as much attention as only a few transition metal carbonyl complexes 
can be found in literature (Figure 1.4), and even fewer have reasonably low 
IC50 values. [54, 56, 57].  
 
Figure 1.4 Examples of transition metal carbonyl complexes with cytotoxic 
activity. 
 
There are two main advantages in incorporating carbonyl ligands in the 
development of anti-cancer therapeutics. One is that the fate of the metal 
complex in the cell can be easily monitored via infrared spectroscopy since the 
carbonyl functionality is known to produce a relatively strong IR signal in the 





allow for diverse substitutions using a large variety of ligands such as 
phosphines, alkenes, pyridines, amines and thiols. This opens up endless 
possibilities for tweaking the cytotoxic properties of the resulting metal 
complex, limited only by the number of ligands available.  
1.1.2 The Role of Iron in Carcinogenesis 
Iron is an abundant element occurring naturally in living organisms and is best 
known for its role in the formation of the oxygen carrier haemoglobin. 
However, besides this well-known function, iron is also involved in a wide 
range of biological processes such as metabolism, cell replication and 
detoxification [59]. Chemically, iron exists in solution as the hydrated 
Fe2+ and Fe3+ cations, and these species undergo facile electron transfer and 
acid-base reactions. This redox capability allows iron to partake in enzymatic 
reaction, but at the same time also enables it to participate in potentially 
deleterious biological events such as free radicals generation. The simplest of 
such events is the Fenton reaction which generates two reactive oxygen 
species – superoxide (O2) and hydroxyl (OH) radical. The Fenton’s reaction 
pathway is outlined in Scheme 1.1. The hydrogen peroxide in the scheme is 
the by-product of aerobic respiration. 
 
 






The superoxide and hydroxyl radicals, collectively termed reactive oxygen 
species (ROS) generated via the Fenton’s reaction are highly reactive and 
destructive. They can potentially damage lipids (fatty acids) and proteins 
(amino acids side chains with reactive groups) which are important 
constituents of organelles such as the mitochondria and nucleus in a living cell. 
In addition, iron in the +3 oxidation state is highly oxidising and can damage 
DNA via strand breakages and base modifications. Therefore, iron in 
biological organisms is considered as both essential and toxic. 
 
 
Scheme 1.2 Potential deleterious pathways taken by the hydroxyl radical 
generated from the Fenton Reaction 
 
The essential yet toxic dual property of iron necessitates a deeper 
understanding of how iron works in a biological system. The recent discovery 
of new proteins that are involved in iron metabolism [60] have now greatly 
facilitated our comprehension of the dual traits of iron in our body. For 
example, newly identified iron efflux pumps [61], iron regulators, oxidases 
and reductases [62-64] have offered scientists a new look at how tumour cells 





valuable knowledge on the relationship between iron and cancer, they have 
also opened up the possibility of a new class of iron-based therapeutics.  
Unfortunately, iron-based complexes exhibiting cytotoxic properties are far 
and few between, with the most classical example being organic derivatives of 
ferrocene as exemplified in Figure 1.4. While encouraging results have 
emerged from the use of iron chelators such as deferasirox and ciclopirox 
(Figure 1.5) as anti-cancer agents, none of them have yet to clear clinical 
trials.  
 
Figure 1.5 Examples of iron chelators undergoing evaluation as anti-cancer 
agents 
 
1.1.3 Comparative Studies with Organic Isothiocyanates 
The anti-cancer activity of modern drugs does not always involve a metal. In 
fact, more often than not; simple organic molecules can be used to trigger cell 
death. For example, the three common chemotherapy drugs deoxcytidine, 
gemcitabine and decitabine (Figure 1.6) are really just simple derivatives of 





investigate and compare the effects of organic isothiocyanates on cell 
proliferation versus that of the organometallic CpFe(CO)2X class of metal 
carbonyl complexes.  
 
Figure 1.6 Some nucleosides derivatives used in chemotherapy 
 
This comparative study was motivated by literature data that showed a 
positive correlation between the consumption of cruciferous vegetables such 
as broccoli, cauliflower and cabbage plants and a reduction in the risk of 
developing cancer [66-68]. This apparent link between the consumption and 
reduction in cancer risk was further verified when Professor Talalay’s group 
first isolated and elucidated the structure of the key molecule [69], now known 
as sulforaphane, that is responsible for the protection against chemical 
carcinogenesis [70-74]. 
The discovery that an isothiocyanate as simple as sulforaphane have anti-
proliferative properties paved the way for the development of other aryl and 
arylalkyl isothiocyanates (Figure 1.7) as an alternative to sulforaphane. This is 
needed because while sulforaphane has reasonably low IC50 value against a 
variety of carcinoma, it is a little too toxic towards normal cell lines (IC50 of 
14 M against human retinal pigment epithelial cells ARPE-19 [73]). Hence 





different from sulforaphane was carried out in the hope that these new 
compounds would have reduced toxicity while at the same time preserved the 
potency of sulforaphane. The efficacy and potency of these compounds will 
also be discussed in Chapter 3. 
 
 
Figure 1.7 Organic isothiocyanates with anti-carcinogenic properties 
 
1.2 Organometallic Complexes as Cell Signalling Agents 
In a living cell, the transmission of information is essential for it to respond to 
its changes in its cellular environment. The cell hence must be able to receive 
and process signals that are outside of its immediate environment. As such, 
cells must function either as transmitters or receivers or both. The mechanism 
of such signalling processes is often facilitated by many different molecules 
ranging from simple gases like nitric oxide, carbon monoxide, hydrogen 
sulfide [75, 76] to small molecules such as steroids to huge proteins 
exemplified by cytokines and hormones (Figure 1.8). These molecules bind 
reversibly to their target receptor under normal physiological conditions and 
exert their effect over short distances (neuronal transmissions across a 





to reach its target receptor. An example of such a signalling molecule is the 
follicle stimulating hormone which has to travel via the blood stream from the 
mammalian brain to the ovaries to exert its effect. In Chapter 4, we will 
synthesize water soluble transition metal carbonyl complexes and use them as 
H2S and CO releasing molecules.  
 
Figure 1.8 Naturally occurring signaling molecules in the human body 
 
1.2.1 NO Releasing Molecules 
Of the three small signalling molecules, the role of nitric oxide (NO) in 
biological systems and its mechanism of action of the various processes it 
mediates has already been researched extensively and is, at present, used 
routinely to treat infants suffering from pulmonary hypertension [77]. Nitric 





life of between 6-30 seconds and being a small, uncharged molecule, it can 
diffuse freely across cell membranes. This molecule is known for its diverse 
range of functions in physiological systems both as a toxin and as a messenger 
molcule. First of all, it is known to regulate vasodilation and certain 
gastrointestinal and urinary functions [78]. NO also supports the immune 
system when it comes under attack from tumours, viruses or other invading 
microorganisms by contributing to the destructive action mediated by the 
macrophages against these foreign bodies [79]. The cardiovascular system is 
maintained by a series of NO regulated processes which include vasodilation, 
inhibition of platelet aggregation [80], and modulation of leukocyte adhesion 
to the endothelium [81]. Different classes of NO releasing molecules are 
exemplified in Figure 1.9 and a summary of the role of NO both as a toxin and 
as a messenger molecule is tabulated in Table 1.1 [82] 
Table 1.1 Physiological and Pathophysiological Roles of Nitric Oxide  
Tissue Messenger Toxin 
Heart 
Coronary perfusion, 
negative inotropic ischemia 
Myocardial “stunning,” 









Acute kidney failure, 
glomerulonephritis 
Immune System Antimicrobial, antitumor 
Antiallograft, graft versus 
host disease, inflammation 
Gastrointestinal 









These critical roles of nitric oxide have driven the research and development 
of a myriad of NO-releasing molecules (NO-RMs) over the past decade. Now, 
moving beyond just molecules with a single function, scientists are diverting 
their attention to the synthesis of multi-functional NO-RMs such as NO-
NSAID and NO-steroids [14] (Figure 1.9). Due to the diverse research 
attention on NO as an important biological messenger molecule, we shall 
focus on the other two gasotransmitters, CO and H2S, in Chapter 4, and hence 
NO releasing molecules will only be touched briefly upon. 
 
Figure 1.9 Examples of NO releasing molecules derived from organic nitrites 






1.2.2 H2S Releasing Molecules 
While the effects of nitric oxide on pathological and physiological processes 
are well-documented, that cannot be said for the other two gasotransmitters 
hydrogen sulfide (H2S) and carbon monoxide (CO). This has caused the 
development of H2S and CO releasing molecules into pharmaceutical agents to 
be slow and sluggish [83]. Therefore the focus of Chapter 5 would be on both 
CO and H2S releasing molecules. Both these gases have similar properties – 
they are both toxic air pollutants but are formed at sufficient levels in cellular 
systems to induce physiological and pathological changes without triggering 
cell death. Thankfully, with increasingly more research studies focusing on the 
elucidation of H2S synthetic and metabolic pathways, this gas is gradually 
being recognized as important signalling molecule. The understanding of how 
H2S is made and the mechanisms of action in vivo would shed some light on 
its role in many pathological and physiological processes [84], thus potentially 
leading to an increased rate in developing drugs that can release H2S in a 
controllable and safe manner. In fact, animal studies using H2S releasing 
agents have shown promise in treating H2S related ailments and several of 







Figure 1.10 H2S releasing molecules currently in clinical trials 
 
Modern era of H2S research probably began when it was discovered that H2S 
generated from sodium hydrosulfide (NaSH), the simplest H2S releasing 
compound, dilates the blood vessels in mouse models in both in vitro and in 
vivo studies [85, 86]. Following this finding, other researchers have reported 
that H2S also dilates rat aorta, gastric artery, and portal vein [85, 87-89], along 
with the mesenteric [90, 91], cavernosal [92], and hepatic vascular beds [93]. 
On top of that, administration of NaSH in live mouse models led to a 
significant drop in blood pressure. Putting together these data and observations, 
H2S clearly has a role to play in maintaining cardiovascular health, and thus 





The molecules in Figure 1.10 have clearly shown that existing H2S releasing 
molecules does not involve organometallic complexes. Inorganic molecules 
such as NaSH and Na2S are commonly used for H2S research. However these 
inorganic salts have no therapeutic value because they release H2S too rapidly 
upon hydrolysis in water. Synthetic H2S donors like those illustrated in Figure 
1.10 are thus predominately the main H2S releasing drugs used in research 
where controlled and sustained H2S release is required. Nonetheless, these 
organic molecules do suffer from certain drawbacks that will constrain the 
progress of H2S research. For instance, these organic H2S donors have been 
found to function only in vitro and not in vivo. Compounds that can release 
H2S in both circumstances have not been found [12]. Furthermore, there is an 
accompanying difficulty in quantifying the concentration of H2S released 
under physiological conditions when such H2S donors are used for research 
studies. 
Hence, Chapter 4 will examine the use of organometallic complexes that act as 
H2S donors. These complexes will carry with them carbonyl ligands as well 
that enables tracking and monitoring via infrared spectroscopy. The distinct 
infrared absorption spectra of the different intermediates before and after H2S 
release makes quantification of the H2S concentration easier. More 
importantly, these organometallic complexes are also water soluble which is 
advantageous for biological experiments and as will be discussed, the 
compounds have minimal cytotoxicity towards normal cells. 
1.2.3 CO Releasing Molecules 
Carbon monoxide has for a long while not been regarded as a molecule that 





‘silent killer’. This belief is changing as research on carbon monoxide as a 
viable therapeutic agent have garnered increasing interest over the last few 
years [94]. Indeed, present data not only demonstrates the protective properties 
of CO during preclinical trials, it also showed no undesirable effects during 
safety assessments and toxicology tests in healthy volunteers [95]. In addition, 
unlike NO and H2S, CO only reacts with transition metals of a specific redox 
state, like iron or manganese, making the development of CO-based drugs 
more versatile and flexible. Hence metal carbonyl complexes present a good 
starting point for the synthesis of complexes carrying varying number CO 
ligands. These organometallic carbonyl complexes that can release CO upon 
photo or thermal activation are termed CO releasing molecules (CO-RMs). 
Figure 1.11 illustrates some metal carbonyl complexes that can behave as CO-
RMs. 
The development of CO-RMs started in 2000 when Roberto Motterlini first 
tested Fe(CO)5, Mn2(CO)10 and [Ru(CO)3Cl2]2 and found that they are 
biologically active [10]. Unfortunately these metal carbonyls are not water 
soluble which presents a problem when dealing with biological systems – that 
the bioavailability of the complex might be insufficient for any therapeutic 
effect to occur. Eventually though, collaboration with Brian Mann saw the 
synthesis of the first water soluble CO-RM, Ru(CO)3Cl(glycinate) [8], which 
was given the designation CORM-3 (Figure 1.12). CORM-3 was tested both 
in vitro and in vivo in mouse models and was found to release CO rapidly (half 






Figure 1.11 CO-RMs based on transition metal carbonyl complexes 
 
 
Figure 1.12 Chemical structure of Ru(CO)3Cl(glycinate) CORM-3, the first 
water soluble CO-RM. 
 
The complexes listed in Figure 1.11 are of course, by no means exhaustive. 
The chemistry of transition metal carbonyl complexes is known to be highly 
versatile and varied as can be seen from the facile substitution of the carbonyl 
functionality with a huge diversity of ligands. This is advantageous as it 





controlled release of the gasotransmitter only when required and only in 
therapeutic doses. In addition, the CO-RMs in Figure 1.11 suggests that there 
is not a transition metal that is preferred over the others in the synthesis of 
CO-RMs. Indeed, CO-RMs containing ruthenium, molybdenum, iron, 
manganese, cobalt are currently being synthesized and evaluated for their 
suitability as CO-RMs [96]. 
The growing interest in the physiological role of CO in biological systems 
requires that new CO-RMs be made available quickly. It can be challenging to 
synthesize new CO-RMs as they require several ideal chemical and bioactive 
properties such as: 
 Non-toxicity 
 Water solubility 
 Controlled release 
 Sufficient stability for administration under physiological conditions 
In addition, fast and easy methods to quantify the amount of CO release in 
biological systems also need to be developed to allow real time monitoring in 
vivo. Current approaches of CO quantification either use myoglobin to 
determine CO content spectrophotometrically or by using a CO electrode to 
make electrochemical measurements. In Chapter 4, we introduce an alternative 
method of CO quantification by means of infrared spectroscopy. 
1.3 Organometallic Complexes as Optical Sensors 
Traditionally, there are two broad categories of optical sensors, those that use 
transmitted or reflected light for sensing and those that rely on fluorescent, 





an analyte. Current progress in the field of optical sensors focus more on the 
design of fluorescent and phosphorescent probes with little research emphasis 
on the development of transition metal based sensors [97-100] that works via 
the use of transmitted light, particularly the visible region of the 
electromagnetic spectrum. 
These phosphorescent and fluorescent probes are typically based on mid- to 
late-transition metals in low oxidation states. Rhenium, iridium and ruthenium 
metal complexes (Figure 1.13) are the most commonly studied examples of 
optical probes used for cell imaging purposes. It is only in the recent years that 
platinum and gold metal complexes started to garner interest in lieu of the fact 
that both platinum [101] and gold [102, 103] are also used as anti-cancer drugs, 
and so this combined imaging and therapeutic application become particularly 
interesting. 
 






With all the hype surrounding luminescent molecules, it is not surprising that 
the development of transition metal carbonyl complexes as molecular sensors 
has been neglected. In literature, transition metal carbonyl complexes that can 
be used as potential sensing agents are far and few between even though 
carbonyl complexes are very versatile reagents with the carbonyl ligand 
playing an additional role as a probe for vibrational microscopy. The CO 
ligand absorbs at between 1900 cm-1 to 2100 cm-1, a region free from potential 
absorptions from background biological materials. Such a property provides 
for a high signal to noise ratio which can be exploited when used as a probe 
for infrared microscopy. 
1.3.1 Organometallic Complexes for Thiol Sensing 
Thiols are biologically important molecules which regulate a variety of 
biological processes in an organism. Of particular importance are those that 
are involved in maintaining redox homeostasis such as glutathione (GSH), 
cysteine (Cys) and homocysteine (HCys). In addition to maintaining redox 
balance, thiols are also known to play a functional role in enzymes catalytic 
sites and metabolic pathways [104]. Indeed, researches have suggested that 
thiols levels, especially that of homocysteine, are linked to a number of 
diseases including Alzheimer’s, cancer and cardiovascular diseases [105-107]. 
Plasma thiol concentrations have also been linked to the oxidative stress levels 
associated with the development of some of these conditions [108-111]. 
In view of the biological importance of thiols, it is not surprising that there 
already exist some analytical methodologies for the detection and 
quantification of thiols. Some well-known instrumental methods include 





118] and electrochemical methods [119, 120]. However, these methods have 
their own drawbacks, for example, high equipment costs, complexity, sample 
processing and run times which make them impractical to be used for studying 
sensitive biological systems and for field applications.  
Compared to instrumental techniques, fluorescence and optical sensing present 
a more viable and attractive option for the detection of thiols. This can be seen 
from the increased research efforts devoted to the development of optical and 
fluorescent sensors for thiols [121, 122] over the last decade. Such optical and 
fluorescent probes have the advantage of sensitivity, simplicity and most 
importantly, potential for in vivo bioimaging which is becoming increasingly 
important in the field of biomedical science [123-125]. Figure 1.14 lists some 
examples of current fluorophores that is used for small molecules sensing. 
These optical probes function via a variety of reaction mechanisms ranging 
from Michael additions [126, 127], cyclization with aldehydes [128, 129], 
cleavages of sulfonamides and sulfonate esters [130-132], cleavage of 
selenium-nitrogen bonds [133-135], redox processes in metal complexes [136-
138], cleavages of disulfides bonds [139-141] to the use of nanoparticles in the 
form of quantum dots [142-146]. Remarkably, metal carbonyls as optical 
probes have not received much attention even though they form highly 
coloured complexes which change colour easily depending on its chemical 
environment. The CO ligand in such metal carbonyl complexes can function 
both as a probe for vibrational spectroscopy and also indirectly act as an 
optical probe by influencing the ligand field of the complex, thereby altering 






Figure 1.14 Common fluorophores selective for thiols 
 
In Chapter 5 we will discuss the utility of a functional radical probe containing 
a manganese carbonyl scaffold. Not only does this probe exhibits different 
absorbance in the visible light region depending on its redox state, the 
preparation of such a radical complex may also serve as a dual probe in 
infrared and fluorescent imaging studies in chemical biology, especially in 
radical-rich environments involving NO and ROS. Interestingly, it also has the 
ability to distinguish between different biological thiols such as between 





1.3.2 Organometallic Complexes for Hydrazine Sensing 
Chapter 5 of this thesis will also include a section describing the application of 
the manganese carbonyl radical in the detection of hydrazine, N2H4. Hydrazine 
has long been established as a highly toxic small molecule and has shown to 
induce cancer of the liver and the nervous system in laboratory animals [147]. 
Because of its molecular size and ease of dispersal, it can be easily absorbed 
into the human body through skin, oral or inhalation routes of exposure. 
Despite the toxicity, however, hydrazine has been, and still is, used 
extensively as a fuel in rocket and missile propulsion systems [148] and is also 
found as a common reactant in fuel cells [149]. A simple molecule possessing 
both reducing and basic properties, hydrazine is widely used in the chemical 
industry for the manufacture of pharmaceuticals, pesticides, dyes and 
emulsions [150, 151].  Due to its ubiquitous yet toxic nature, there is a need 
for reliable and sensitive methods to detect hydrazine and its derivatives. 
Current analytical techniques for the detection of hydrazine include, but are 
not limited to, spectroscopic [152-154], potentiometric [155, 156], 
chemiluminescence [157] and chromatographic [158]. These techniques 
although well established, are often not easy to apply and may require 
expensive instrumentation which would not be ideal for real time monitoring 
and field applications. An inexpensive and convenient method that has been 
used to detect a variety of ionic and neutral analytes is the use of chromogenic 
probes that changes colour in the presence of the molecule of interest. 
Strangely, even though several of such optical probes have already been 
developed for the detection of a variety of cations, anions and neutral 





optical probes for hydrazine. Therefore, a section in Chapter 5 will examine 
the use of a manganese carbonyl probe to detect and quantify hydrazine. 
 
Figure 1.15 Chemical probes used for the detection of various neutral (black), 






1.4 Project Focus and Thesis Organization 
Transition metal carbonyl complexes have provided chemists a means to 
monitor the fate of the complex via infrared spectroscopy. This has allowed 
many catalytic mechanisms to be elucidated and hence transition metal 
catalysis is still widely researched in many laboratories. The use of transition 
metal carbonyl complexes in the area of biomedical applications is still in its 
infancy and much more can certainly be done to bring newer and more 
efficient drugs, sensors and signalling molecules into the commercial market. 
The focus of this thesis is therefore to search for new metal carbonyl 
complexes that have potential applications in the biomedical industry.  
Chapter 2 will touch upon the potential anti-cancer activity of an iron-based 
carbonyl complex with a half sandwich scaffold – CpFe(CO)2. Similar to 
ruthenium and osmium half sandwich complexes, the iron analogue also 
retards cancer cell proliferation via apoptosis, without the accompanying 
cytotoxic effects towards normal cell lines. The use of a metal complex with a 
carbonyl ligand can provide us an alternative means to monitor via infrared 
spectroscopy the fate of the complex upon entering a biological system. A 
total of seven Fp complexes were synthesized using published methods and 
their cytotoxic properties were evaluated against three different cell lines (ER 
breast carcinoma MDA-MB-231, ER+ breast carcinoma MCF-7 and HeLa cell 
line). These cytotoxicity data were then compared with normal cell lines 
MCF-10A (normal mammalian breast cells), TAMH (Transforming growth 
factor alpha mouse hepatocyte) and HL-1 (Mouse cardiomyocyte derived from 





In Chapter 3, we begin to explore the efficacy of organic isothiocyanates as a 
metal-free anti-cancer therapeutics. This study arose because it has been 
reported that sulforaphane (an isothiocyanate) was found to exhibit chemo-
protective properties to a variety of cancer cell lines. Work then began to 
synthesize organic molecules carrying the isothiocyanate moiety which was 
then evaluated against the breast cancer cell line. Chapter 3 also discusses the 
differences in the cell viability assays between an organic isothiocyanate 
versus a metal-bearing isothiocyanate in order to establish whether the 
presence of a redox active metal increases or decreases the anti-proliferative 
activity of the molecule. In addition, several modifications to the CpFe(CO)2 
core such as the modification of the cyclopentadienyl ring and changing the 
metal centre, was also carried out and the effect of the change was then 
evaluated against the cancer cell lines. 
Chapter 4 moves away from anti-cancer complexes and being to discuss the 
utility of transition metal carbonyl complexes as CO and H2S releasing 
molecules, both of which are important gasotransmitters in a biological system. 
In this chapter, water soluble complexes were synthesized and subjected to 
different conditions to induce the release of the respective gasotransmitters. 
Different analytical methods were used to track and quantify the amount of 
gases released during the course of the reaction. 
In Chapter 5, a manganese based carbonyl complex was developed and used to 
detect and distinguish between different thiols, which are crucial and 
ubiquitous molecules occurring in the amino acid cysteine and the antioxidant 
glutathione. These thiols have important roles in mammals and therefore it is 





thiols at any time during in vitro or in vivo experiments. The reaction of 
different thiols with the manganese complex induces a change in the UV-vis 
absorption spectrum over time. These changes can be easily monitored with a 
UV spectrometer after which Beer’s Law can then be applied to calculate the 










Chapter 2 Transition Metal Carbonyl 
Complexes as Anti-Cancer Agents 





The success of cisplatin in testicular cancer treatment has led to much research 
interest in the discovery of organometallic anti-cancer compounds [39, 40, 161] 
such as arene ruthenium [3, 4, 37, 162, 163], ferrocene derivatives [164-166] 
(which was also discussed in an excellent review paper [167]) and metal 
carbene complexes [168-170]. Although not as prevalent, transition metal 
carbonyl complexes have also been featured as anti-cancer compounds since 
the first demonstration of cytotoxicity by alkyne hexacarbonyldicobalt species 
[171-174]. An iron carbonyl diene nucleoside complex has been shown to 





complexes bind strongly to estradiol receptor sites in breast cancer cells [177, 
178]. Osmium carbonyl clusters [57] have been used as a new class of 
apoptosis-inducing agents while an iron dithiocarbamate carbonyl complex 
used as a CO-releasing molecule (CORM) has exhibited anti-cancer activity 
[179]. Manganese carbonyl N-heterocycles have demonstrated photo-induced 
cytotoxicity [180-182] and half-sandwich cymantrene peptides conjugates 
synthesized by Schatzschneider group have also demonstrated potential in 
anticancer chemotherapy [183-185]. 
Our motivation in using inexpensive iron carbonyls as anti-cancer agents came 
during in vitro testing of organic and inorganic isothiocyanates on ER- breast 
carcinoma cancer cells (MDA-MB-231). We discovered that cyclopentadienyl 
iron dicarbonyl isothiocyanate CpFe(CO)2NCS demonstrated more potent 
cytotoxicity towards these cells, compared to sulforaphane, an organic 
isothiocyanate found in cruciferous vegetables [70, 74]. Interestingly, the 
normal cells are unharmed by the iron complexes. This promising result 
initiated a series of experiments to evaluate the cytotoxicity of CpFe(CO)2X 
class of complexes on MDA-MB-231 cells as well as the more widely 
researched HeLa cell-line. Indeed, our results have suggested that even 
without the isothiocyanate functionality, these metal complexes are still 
cytotoxic, and may have triggered cancer cell death via a different mechanism. 
2.2 Results  
2.2.1 Chemistry of Cyclopentadienyl Iron Dicarbonyl Complexes 
Seven iron complexes of formula CpFe(CO)2X  (1 to 7, Scheme 2.1) and for 





Re2(CO)10 (9) and Mn2(CO)10 (10), were tested for cytotoxicity against MDA-
MB-231 breast cancer cells and HeLa cervical cancer cells. Complexes 1, 2, 4, 
5 and 6 were prepared according to slightly-modified literature methods [186, 
187] while 3, 7, 8, 9 and 10 were commercially available. 
 
 
Scheme 2.1 Chemical structure of the 10 metal carbonyl complexes evaluated 
for anti-cancer activity 
 
To complete the structural characterization of the complexes in Scheme 2.1, 
the X-ray single crystal structures of red CpFe(CO)2SCN 4, (Figure 2.1) and 
its yellow isomer, CpFe(CO)2NCS, 5, were obtained (Figure 2.2). The Fe-N-
C-S moiety in 5 is close to linearity with a bond angle of 178.90(3) and the 
short N≡C bond of 1.159(5)Å adopting triple bond character. A bent Fe-S-
CN angle of 100.96(17) due to lone pair repulsion is determined in 4 as 





1.163(7)Å. The C≡N bond lengths in both isomers are similar to those found 
in organic thiocyanates and isothiocyanates. The more efficient 
backbonding from the NCS functionality to the iron center in the linear Fe-
NCS fragment of 5 also leads to slightly higher CO values. 
 
Figure 2.1 X-ray crystal structure of 4 with thermal ellipsoids at 50% 
probability 
 







2.2.2 Biological Evaluation 
The IC50 values for 1 to 10 evaluated against ER- breast carcinoma cancer 
cells (MDA-MB-231) and HeLa cervical cancer cell line in DMSO solvent are 
shown below in Table 2.1. The values were obtained after 24 hour incubation   
Table 2.1 IC50 values of Fp derivatives versus the commercially known metal 
dimers.  
[IC50] / M 
Class of Complex Complex MDA-MB-231 HeLa 
CpFe(CO)2X 
1 17.3  1.3 18.3  1.2 
2 10.5  1.2 13.7  1.2 
3 3.0  1.1 6.7  1.1 
4 3.4  1.1 7.0  1.1 
5 3.8  1.1 8.0  1.2 
6 8.7  1.1 9.0  1.0 
7 13.6  1.2 15.5  1.2 
Transition Metal 
Carbonyl Dimers 
8 >200 >200 
9 >200 >200 
10 >200 >200 
 
All the iron complexes 1 to 7 showed cytotoxicity towards the cancer cells 
with IC50 values ranging from 3.0 M to 17.3 M, with 3 being the most 
potent over a 24-hour incubation period. The presence of the SCN/NCS group 
in 4 and 5 does not appear to impart additional cytotoxicity as compared to the 
rest of the CpFe(CO)2 derivatives. In contrast, dimers 8, 9 and 10 do not show 
appreciable cytotoxicity. Remarkably, all the complexes are not cytotoxic 
towards the corresponding normal mammary epithelial cells MCF-10A and 
two other normal cell lines, TAMH (Transforming growth factor- alpha mouse 





cardiomyocyte tumor lineage) [188]. IC50 values could not be determined 
since the normal cell viabilities over the tested concentration range remains 
close to 100%. Although the IC50 values for cancer cell cytotoxicity are not in 
the nM (nanomolar) range, the iron complexes induce only cancer cell death 
while leaving normal cells intact.  
 
 
Figure 2.3 Dose-response curves of complex 3 for HeLa (top) and MDA-MB-
231 (, bottom) cell line. The normal cell line MCF-10A (, bottom) has been 
co-plotted together on the MDA-MB-231 IC50 curve. 
CpFe(CO)2I (3)
























The effect of the iron complexes on the cancer cells can be observed by light 
microscopy (Figure 2.4). The cancer cells are initially of regular shape with 
the cellular membranes clearly visible and defined. The cells are round in 
shape as they have been trypsinized prior to imaging. After treatment with 
complex 3 for 24 hours, the cells become irregularly-shaped because of the 
decoupling of the cytoskeleton from the plasma membrane followed by 
eventual loss of cytoplasmic material. The nuclei are now not as clearly visible 
and the cytoplasmic membranes are no longer well-defined. This blebbing 
process is widely believed [189-191] to be an indicator of apoptosis. This 
observation is consistent with the flow cytometry and confocal data (Figure 
2.5 and 2.6) which indicates that the cells treated with 5 M of 3 undergo 
early apoptosis (AV+/PI-). Increasing the dosage to 10 M causes a larger 
proportion of the cells to proceed to late apoptosis phase (AV+/PI+). 
 
Figure 2.4 Bright field image at 400 magnification of MDA-MB-231 
mammary cancer cells before (left) and after (right) treatment with 3. Both 
images were obtained after treatment with 40 M of complex 3 for 24 hours at 
37C. The cells in the left image have been trypsinized and show the presence 
of an intact cell membrane. The right image shows multiple blebs (indicated 






Figure 2.5. Confocal image of MDA-MB-231 cells after treatment with 40 
M of 3 (left) and 7 (right).Both images are doubly stained with Annexin V 
Alexa Fluor 488 and PI and taken at 600 magnification. The nucleus (red) is 
observed to be swollen together with the presence of blebbing (green) suggests 
that the cell is undergoing late apoptosis. Blebbing is again observed together 




Figure 2.6 Flow cytometry data of HeLa (top) and MDA-MB-231 (bottom) 







Figure 2.7 Confocal image acquired at 10 magnification of MDA-MB-231 
(top) and HeLa (bottom) cells. The cells were treated with 5 M, 10 M and 
20 M of 3 for 24 hours at 37C and stained with Annexin V and PI. 
 
In order to shed more insight into the mode of action of the iron complexes 
towards cancer cells, 3 and 7 have been chosen for further study. Studies into 
their water-solubility, permeability across a membrane, metabolic stability and 
cytotoxicity towards other normal cells were carried out. The respective 
solubility of 3 and 7 in water have been determined to be 141  20 M and 31 
 2 M. These values were determined by first dissolving weighed amounts of 
3 and 7 with stirring in a known volume of deionized water until the first sign 
of excess solids were seen at the bottom of the cuvette. The UV-vis 
absorbance was then monitored until it reaches a constant value for at least an 
hour. The UV-vis spectra of the complexes in water and in hexane also 
appeared similar hence 3 and 7 should still be structurally intact without 






Figure 2.8 Metabolic stability studies of complex 3 in both MRLM (▲) and 
FRLM (•) versus a positive control, midazolam (■). 
 
Figure 2.9 Metabolic stability studies of complex 7 in both MRLM (▲) and 


































Figure 2.10 Permeability studies of complexes 3 and 7 using lecithin as the 
barrier, as compared against some established drugs after 6 hours of 
incubation. 
 
Figure 2.11 Permeability studies of complexes 3 and 7 using lecithin as the 



























































Figure 2.12 Decay of carbonyl stretching frequency of 3 () and 7 () upon 
reaction with 30% hydrogen peroxide. 
 
The in vitro metabolic stability of 3 and 7 was studied by assessing the 
percentage loss of the complexes over time in the presence of pooled rat liver 
microsomes (MRLM) [192] (Figure 2.8 and Figure 2.9). An estimate of 
the in vitro degradation half-life (t1/2) and intrinsic clearance (CLint) can then 
be determined. Compare to midazolam, a compound which is rapidly 
metabolized, complex 3 is shown to be very slowly metabolized in rat liver 
microsomes and hence is regarded as metabolic-stable. However 7 is only 
moderately stable under the same conditions.  
The effective permeability of these two complexes was determined by the 
parallel artificial membrane permeation assay (PAMPA) which is widely 
employed in the pharmaceutical industry to predict oral absorption potential of 
early drug candidates (Figure 2.10 and Figure 2.11) [193-195] The PAMPA 























after 16 hours of incubation. In fact the effective permeability of 3 is even 
higher than verapamil, a drug which already exhibits high permeability for the 
period of testing. In contrast, 7 does not show measurable permeability across 
lecithin.   
Chemical reactivity studies carried out on 3 and 7 showed that they do not 
react with natural amino acids such as glycine (control), lysine (amine), 
tyrosine (phenol), histidine (imidazole), serine (aliphatic alcohol), methionine 
(sulfide) and cysteine (thiol) at 35oC to 40oC over a period of 12 hours. This 
conclusion was derived from the monitoring of the CO infrared stretching 
signals of 3 and 7 after the addition of the respective amino acids in DMSO. In 
particular, this inactivity towards cysteine suggests that these iron complexes 
operate via a different mode of action in cellular growth inhibition contrary to 
organic isothiocyanates which target cysteine residues on the Keap1 protein 
[72, 73, 196] Radical-mediated cell apoptosis pathways have also been 
considered, since the dimers 7 to 10 are well-known precursors to reactive 
mononuclear metal-centered radicals upon thermal or photochemical 
excitation [197]. The presence of such radicals in a cell environment could 
disrupt radical-dependent cell cycles. However the lack of cytotoxicity 
exhibited by 8, 9 and 10 lends little support to a direct radical-mediated cell 
death. In addition, the role of 3 and 7 as CORMs is also unlikely. If CO 
release triggers cell death directly, all the tested metal carbonyls would have 
shown similar cytotoxicity effects.     
The IC50 values listed in Table 2.1 suggests that cell death is brought about by 
the presence of the CpFe(CO)2 moiety. Studies [198-200] have shown that 





cancer cells, which promotes the Fenton reaction in which Fe2+ is oxidized to 
Fe3+. The feasibility of this reaction was tested using hydrogen peroxide to 
represent an ROS. Indeed, the CO IR absorbance of 3 and 7 showed a 
decrease against time, albeit at a much lower decomposition rate compare to 
FeSO4, a typical iron salt used in the Fenton test (Figure 2.11). Upon 
completion of the reaction, a further chemical test with potassium thiocyanate 
turns the solution mixture red, indicating the presence of Fe3+. Complexes 3 
and 7 therefore are possible Fenton-type catalysts which might have disrupted 
ROS-mediated cell cycles leading to premature cancer cell death [201]. In 
contrast, the much lower ROS concentration present in normal cells may have 
mitigated the impact caused by the iron complexes.  
2.3 Conclusion 
In conclusion, we have shown that cyclopentadienyl iron carbonyl complexes 
are cytotoxic towards breast cancer cells but not normal cells with IC50 values 
of ranging from 3.0 M to 17.3 M. These complexes are structurally similar, 
each containing a CpFe(CO)2 core with a differing functional group directly 
bonded to the iron center. With other metal carbonyls dimers, no significant 
cytotoxicity on the cancer cells was observed. As such, it is inferred that it is 
the CpFe(CO)2 moiety that is largely responsible for the cytotoxic 
observations. The functional group on the iron does not appear to influence the 
cytotoxic properties of the complex as exemplified by the isothiocyanate 
complex 5. These half-sandwich iron complexes are inexpensive, either 
commercially available or easily prepared. In particular, 3 is metabolic-stable 
and demonstrates good permeability across a lipid barrier and could be a 





remains to be elucidated, it is believed that the pathway to cellular death may 
be associated with Fenton-like reactions caused by the [CpFe(CO)2]
+ species.  
2.4 Experimental 
2.4.1 Materials 
Cyclopentadienyl iron dicarbonyl dimer [CpFe(CO)2]2, cyclopentadienyl 
dicarbonyl iodide [CpFe(CO)2I], cyclopentadienyl molybdenum tricarbonyl, 
[CpMo(CO)3]2, rhenium carbonyl [Re2(CO)10], manganese carbonyl 
[Mn2(CO)10], tetrachloromethane, dichloromethane, bromine, potassium 
thiocyanate, silver (I) tetrafluoroborate, ethanol, hexane and chloroform were 
purchased from Sigma-Aldrich. Penicillin-Streptomycin was obtained from 
GIBCO laboratories. Thiazolyl blue (MTT) was obtained from Promega. 10 
Phosphate Buffered Saline (PBS) pH 7.4, Dulbecco's Modified Eagle's 
Medium (DMEM) Fetal Bovine Serum (FBS) were purchased from Thermo 
Fisher Scientific Inc. (Logan, UT, USA). Ultrapure water used was purified by 
a Milli-Q UV purification system (Sartorius Stedim Biotech SA, Aubagne 
Cedex, France). Annexin V/PI cell viability assay stains were purchased from 
Life Technologies. The HeLa, MDA-MB-231, MCF-7, MCF-10A cell lines 
were received with appreciation from Professor Paul Ho from the Department 
of Pharmacy, National University of Singapore and Professor Leong from 
School of Physical and Chemical Sciences, National Technological University. 
The TAMH and HL-1 cell line were cultured in Professor Brian Dymock 





2.4.2 Instrumentation and General Methods 
All manipulations for chemical synthesis were carried out using standard 
Schlenk techniques under a nitrogen atmosphere. Photochemical experiments 
were conducted with a Legrand broadband lamp (350 – 800 nm, 11 W). All 
infrared spectra were obtained with Shimadzu IR Prestige - 21 Fourier – 
transformed infrared spectrometer (1000 – 4000 cm-1, 1 cm-1 resolution, 16 
scans co–added for spectra averaging) using a 0.05 mm path – length CaF2 cell 
for liquid samples. Electrospray ionisation (ESI) was conducted using a 
Finnigan MAT LCQ spectrometer. 1H and 13C NMR spectra were recorded 
using Bruker AMX 300 Fourier Transform Spectrometer operating at 300 
MHz for proton and 75 MHz for carbon nuclei at room temperature, using 
CDCl3 as solvent unless otherwise stated. The chemical shifts were referenced 
to tetramethylsilane and are reported in ppm. 
2.4.3 Solid State Structural Determination 
Single crystal X-ray structural studies were performed on Bruker-AXS Smart 
Apex CCD Single-Crystal Diffractometers by CMMAC, National University 
of Singapore. Data were collected at 100(2) K using graphite-monochromated 
Mo Kα radiation (λ = 0.71073 Å). Data collection was evaluated using 
SMART CCD system and processed for Lorentz and polarisation effects using 
SAINT software and for absorption effects using SADABS software. 
Structural solution and refinement were then carried out using SHELXTL 
suite of programs. The structure was solved by direct methods. All H atoms 





2.4.4 Syntheses of 1, CpFe(CO)2Cl and 2, CpFe(CO)2Br 
CpFe(CO)2Cl, CpFe(CO)2Br and CpFe(CO)2
+BF4
- were synthesized according 
to literature methods [187]. Briefly, 1 molar equivalent of [CpFe(CO)2]2 was 
dissolved in tetrachloromethane and refluxed until the bridging CO peak of the 
dimer starting reactant has completely disappear. The product was then passed 
through a silica column and the orange product eluted using 100% ethyl 
acetate. CpFe(CO)2Br was synthesized in a similar way except that the dimer 
was refluxed with bromine in hexane. Yield 1: 90%, 2: 88%. IR CpFe(CO)2Cl 
(chloroform, max, cm−1): 2012s, 2057s (C=O). IR CpFe(CO)2Br (ethyl acetate, 
max, cm−1): 1999s, 2045s (C=O).  
2.4.5 Syntheses of 4, CpFe(CO)2SCN and 5, CpFe(CO)2NCS 
Both isomers, CpFe(CO)2NCS and CpFe(CO)2SCN, were obtained via a 
modified method [186]. Briefly, 1 molar equivalent of [CpFe(CO)2]2 dimer 
was dissolved in absolute ethanol. 3 molar equivalents of potassium 
thiocyanate and 0.6 ml of tetrafluoroboric acid were added under ambient 
conditions with vigorous agitation. The solvent was then removed under 
reduced pressure after 1 hour and the two isomers separated via column 
chromatography using silica as stationary phase and dichloromethane as the 
mobile phase. IR absorption bands conform to the data published previously 
[202]. Crystals suitable for x-ray analysis were grown from hexane. Yield 4: 
54%, 5: 33%. IR CpFe(CO)2NCS (dichloromethane, max, cm−1): 2023s, 2067s 
(C=O), 2118m (C=N). IR CpFe(CO) 2SCN (dichloromethane, max, cm−1): 





2.4.6 Synthesis of 6, CpFe(CO)2+BF4- 
The synthesis of 6 was accomplished via a modified literature method [187]. 1 
molar equivalent of CpFe(CO)2I was dissolved in dichloromethane and 1.1 
molar equivalents of silver tetrafluoroborate was added. The mixture was 
stirred for 2 hours under nitrogen at room temperature. An orange solution of 
the cation was obtained after the filtration of yellow silver iodide. IR 
CpFe(CO)2
+BF4
- (dichloromethane, max, cm−1): 2001, 2046 (C=O). 
2.4.7 Reactions of 3 and 7 with H2O2 
4 mg of 3 (13 mol) was dissolved in 2 ml of THF. 5 molar equivalents of 
aqueous hydrogen peroxide (30%) were then added swiftly and the mixture 
stirred vigorously under nitrogen. The changes in carbonyl absorption 
intensity of 3 at 2042 cm-1 were recorded at every 30 minutes interval until the 
signal becomes indistinguishable from background noise. The same procedure 
was carried out for the reaction between 7 (10 M, CO band at 1790 cm-1) and 
hydrogen peroxide in the same solvent. 
2.4.8 Cell Culture and Drug Treatment  
The cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, 
Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS), 1% 
l-glutamate (GIBCO Laboratories), and 1% penicillin/streptomycin (GIBCO 
Laboratories) at 37C in 5% CO2 atmosphere. Compounds 1 to 10 were 
dissolved in DMSO and serially diluted until the final concentration used for 
incubation were 0.01 µM, 0.1 µM, 1 µM, 5 µM, 10 µM, 20 µM, 40 µM, 100 
µM and 200 M. The treatment of the cells was performed by seeding the 





incubated for 24 hours to allow adhesion and growth before treatment (80% 
confluence). The media was then removed and the cells washed once with 
PBS and then treated with the various concentrations of the compounds in 
DMEM only. Control cells were treated with 0.1% DMSO. All 4 cell lines 
were treated in the same manner. All final DMSO concentrations are at 0.1%. 
2.4.9 Annexin V and PI Staining for Flow Cytometry 
The percentage of cells actively undergoing apoptosis was determined using 
Annexin-V Alexa Fluor 488 based immunofluorescence, as described 
previously [203]. Briefly, cells were plated onto a 24-well dish and allowed to 
reach 80% confluence. The cells were then treated with a positive control, 
negative control and 5 M and 10 M of 3 and 7 separately. Figure 2.13 
shows the plate distribution of the drug and the various controls. After 24 
hours, the cells were trypsinized, centrifuged at 150 RCF and double-stained 
with 2.5 L of Annexin-V and 0.5 L of propidium iodide (PI). An incubation 
time of 15 minutes were allowed after addition of the antibody and PI stain 
prior to flow analysis. The cells were then analyzed using BD LSRFortessa 
instrument running BD FACSDiva software. All experiments were performed 






Figure 2.13 Distribution of blank (white), DMSO control (red), positive 
control of cis-platin (blue), negative control (cyan) and cells treated with 3 
(yellow) and 7 (green) on a 24 well plate.  
 
2.4.10 Confocal Microscopy 
High resolution images were obtained using Olympus Fluoview FV300 
confocal laser scanning microscope at 400 and 600. Cells were seeded on 
coverslips at a density of 1  105 cells per well in DMEM growth medium 
supplemented with 10% FBS and 1% penicillin/streptomycin and allowed to 
reach 80% confluence over 24 h. They were then treated with 5 M, 10 M 
and 20 M of 3 for 24 h. After treatment, the cells were washed with PBS, and 
stained with Annexin V and PI, then washed again with PBS and subsequently 
mounted onto a glass slide, examined and photographed. Apoptotic cells were 
defined based on the distribution of the Annexin V and PI stains. Early 
apoptotic cells were defined by Annexin V positive, PI negative (AV+/PI-). 
Necrotic and late apoptotic cells were defined by Annexin V and PI positive 





2.4.11 MTT Proliferation Assay 
The anti-proliferation activity of the CpFe(CO)2X complexes were determined 
using MTT assay. Approximately 10,000 cells per well were seeded in a 96-
well plate and allowed to adhere for approximately 24 hours at 37C. The cells 
were then treated with varying concentrations of the complexes in media for 
another 24 hours and then left to incubate in a 37C incubator with 5% CO2. 
The final concentration of DMSO in the medium was 0.1% (v/v). Following 
treatment, the media was removed and each well washed with 100 L of PBS, 
followed by 100 L of MTT, (0.5mg/mL) in media and incubated for an 
additional 2 hours. After the incubation period, the MTT was removed and 
100 L of DMSO was added to dissolve the formazan crystals. The 
absorbance intensities at 470 nm were then measured and cell viabilities 
relative to the control (DMSO) were calculated. The IC50 values, which is 
defined as the concentration necessary to inhibit the growth of 50% of the cell 
population were then determined using Graphpad Prism version 5.0 by fitting 
the values on a dose-response curve (Cell viability vs log drug concentration). 
The experiments were performed in triplicates for each concentration and 
three independent experiments were performed. 
2.4.12 Light Microscopy 
10,000 cells were each seeded onto a glass cover slips placed in a 6-well dish 
and allowed to reach 80% confluence in DMEM media. The cells were then 
treated with 20 M and 40 M of 3. After 24 hours, the media was removed 
and the cells washed twice with PBS. The cover slips were then mounted onto 






2.4.13 Determination of the In Vitro Metabolic Stability of 3 and 7 
Pooled male and female rat liver microsomes were obtained from 
BD Gentest Corp. (Woburn, MA, USA). Milli-Q water (Millipore Corp., 
Milford, MA, USA) was used throughout the experiment. All other chemicals 
and reagents were of analytical grade and solvents were of HPLC grade. An 
Agilent 1100 series high performance-liquid chromatography system with 
diode array detector (Agilent Technologies, Waldbronn, Germany) was 
employed for chemical analysis. 
Chromatographic separation was performed on an Zorbax Eclipse Plus C18 
column (2.1  100 mm, i.d., 3.5 μm, Agilent Technologies, Palo Alto, CA, 
USA) with a Security Guard Cartridge (3.0  4 mm, Agilent Technologies, 
Palo Alto, CA, USA) on isocratic elution using a mobile phase consisting of 
methanol–water (45:55, v/v) at a flow rate of 1.2 mL/min with UV detection at 
262 nm. For sample analysis, a 20 µL sample injection was used. Phosphate 
buffer (100 mM, pH 7.4) containing 1 mM EDTA was prepared from 400 mM 
mono- and dibasic potassium phosphate stock solution. NADPH stock 
solutions (10 mM) in phosphate buffer were freshly prepared daily. 
Liver microsomal incubations were conducted in triplicate. Incubation 
mixtures consisted of 7.5 µL of 20 mg/mL FRLM and MRLM (final: 0.3 mg 
microsome protein/mL), 2.5 µL of 600 µM of complexes 3 or 7 in acetonitrile 
(final: 3 µM), 440 µL of 0.1 M phosphate buffer (pH 7.4). The mixture was 
first shaken for 5 min for pre-incubation in a shaking water bath at 37C. 
Reaction was initiated by adding 50 µL of 10 mM NADPH to obtain a final 





reaction mixture was 500 µL. For metabolic stability studies, aliquots of 50 µL 
of the incubation sample mixture were collected at 0, 5, 10, 15, 30, and 45 min. 
After collection of samples, the reaction was terminated with 100 µL of 
chilled acetonitrile. The mixture was then centrifuged at 10,000 g to remove 
the protein and the supernatant was subsequently applied to LC analysis.  
Positive control (PC) samples were prepared as described above, except the 
test compound was replaced with the known P450 substrate (Midazolam, 3 
µM). The samples were assayed for the degradation of midazolam to evaluate 
the adequacy of the experimental conditions for drug metabolism study. 
Negative control samples were also prepared as described above but without 
NADPH. 
In the determination of the in vitro half-life (T1/2), the peak areas of drug were 
converted to parent remaining percentages using the t = 0 peak area values as 
100%. The remaining percentages of the candidate were plotted against the 
microsomal incubation time. Data points were determined from the average of 
three measurements with standard deviations as the error bars. The in vitro T1/2 
(in units of min) was calculated from the slope of the linear regression (k) of 
the natural logarithm of the parent remaining percentage versus incubation 
time according to the following formulae.  
Equations: 
T1/2 = 0.693/k (min)                                                          
V (L/mg) = Volume of incubation / amount of microsomal protein in the 





CLint, in vitro = V x 0.693 / T1/2  (L/min/mg protein)                                 
CLint, app = CLint (45 mg microsomal protein/g of liver) (45 g of liver
*/kg body 
weight) *20 and 45 g of liver/kg of body weight were used for human and rat, 
respectively. 
2.4.14 Determination of the Permeability of Complexes 3 and 7  
The effective permeabilities (Pe) of 3 and 7 were determined by the parallel 
artificial membrane permeation assay (PAMPA) which is widely employed in 
the pharmaceutical industry to predict oral absorption potential of early drug 
candidates. Permeability was assessed at pH 7.4 over 2 different permeation 
time, 6h and 16h, at ambient temperature. Caffeine, quinidine, verapamil, 
carbamazepine, warfarin, (±)-propranolol hydrochloride, L-α-
phosphatidylcholine (lecithin) (Lyophilized powder from egg yolk) and the 
phosphate buffer saline (PBS) solution were also obtained from Sigma Aldrich. 
12 mM stock solution for each of the complexes 3 and 7 was prepared in 
DMSO. Calibrators were made in 1 PBS solution and diluted to give 
solutions of 120 µM, 60 µM, 30 µM, 15 µM, 7.5 µM, 3.75 µM, 1.875 µM,  
and 0.9375 µM. 250 µL of each calibrator solution was transferred to HPLC 
PP vials and analysed by HPLC-UV (254 nm). 50mM stock solution of each 
of the standards (caffeine, carbamazepine, quinidine, verapamil, propranolol, 
warfarin) was prepared in DMSO and diluted with 1 PBS to give standard 
calibrator solutions of 500 µM, 250 µM, 125 µM, 62.5 µM, 31.25 µM and 
15.62 µM.  The concentration of DMSO in each solution was kept at 1% (v/v). 





in a 96-well plate. The UV/Vis absorbance of each well was read at max of the 
standard compound to give its calibration curve.  
A 1% solution (w/v) of lecithin in dodecane was prepared and 5 µL of this 1% 
lecithin/dodecane solution was pipetted into the well of the donor plate. 12 
mM stock solution of 3 was prepared in DMSO. 10 µL of the 12 mM stock 
solution was diluted with 990 µL of 1 PBS buffer to give a 120 µM solution. 
The final concentration of DMSO in the solution is 1% (v/v). 300 µL of this 
solution was added to the well in the donor plate (with lecithin). 300 µL of 1 
PBS buffer (containing 1% v/v DMSO) was added into the corresponding well 
in the acceptor plate. The donor plate was placed on top of the acceptor plate. 
The underside of the membrane in the donor plate must be in contact with the 
buffer in the acceptor well. The donor/acceptor plate unit was covered, placed 
in an air-tight container and agitated in an incubator (250 rpm, 6 hours) at 
temperature of 30.0oC (± 2.5 oC). After this time, 250 µL per well of the donor 
and acceptor plates were transferred to separate HPLC PP vials. The 
concentration of analyte present in each sample were analyse by HPLC-UV 
(254 nm). The assay was repeated using a 2nd stock solution (12 mM) of 3. 
The Effective Permeability Pe was calculated from the equation below [195]. 
𝑃𝑒 = −2.303 ×
𝑉𝐴𝑉𝐷



















(i)  CA   = concentration of test compound in acceptor well after period of 





(ii) CD (0) = concentrations of test compound at time 0   
(iii) CD (t) = concentrations of test compound in donor wells after period of 
incubation (6 h or 16 h). 
(iv) VA= volume of acceptor well (0.3 cm
3)   
(v) VD = volume of donor well (0.3 cm
3) 
(vi) A = filter area 
(vii) t = permeation time (21600 s or 57600 s)  
(viii) S = fraction of the sample remaining in the donor and the acceptor 
wells after permeation time 
2.4.15 Chemical Reactivity Studies 
The reaction of 3 and 7 with various amino acid substrates were evaluated as 
follow. 10 mg of 3 was first dissolved in 50 mL of DMSO. The initial infrared 
spectrum was obtained. Following that, 1 mole equivalent of the various 
amino acids was added separately to the solution of 3 and the solution warmed 
and maintained using a water bath at a temperature of 40C. The IR bands 
were then monitored over 12 hours and conclusions were inferred from the 
changes to the infrared absorptions bands. The same procedure was also 
applied to 7 to evaluate its chemical reactivity. 
2.4.16 Water Solubility and Stability Experiment 
0.100 mg portions of 3 and 7 was each separately added with stirring to 50 mL 
volume of deionized water until the first sign of excess solids were seen at the 
bottom of the cuvette. The experiment was then repeated three times to get an 





monitored until it reached a constant value for at least an hour to evaluate the 














Chapter 3 Structural Modification Studies 
of ‘Hit’ Complexes 




3.1 Introduction  
In Chapter 2, we have identified CpFe(CO)2X carbonyl complexes as potential 
anti-cancer agents and found that they have indeed anti-proliferative properties 
with reasonably low IC50 values, so termed ‘hit’ complexes. In this chapter, 
modifications to the structure of the ‘hit’ complexes are performed to assess 
whether these ‘hit’ complexes identified in Chapter 2 can be made more potent. 
One of the ‘hit’ complex of particular interest is CpFe(CO)2NCS. This 
complex is interesting because the isothiocyanate functional group which it 





observed in organic isothiocyanates [69-74]. These organic isothiocyanates 
destroy cancer cells by strongly inducing the expression of phase II genes. 
These genes when switched on, code for enzymes that are responsible for the 
metabolism of xenobiotics and carcinogens and are termed phase II enzymes. 
A simplified schematic of the mechanism of phase II enzyme induction is 
shown in Figure 3.1. In this sense, organic isothiocyanates trigger cancer cell 
death via a different mechanism as compared to their organometallic 
counterpart, which induces apoptosis via a Fenton-type reaction. The question 
now is to establish whether the presence of a metal would have altered the 
mechanism of action in inducing cellular death. Hence a series of different 
organic isothiocyanates were synthesized for the purpose of the comparison 
with the metal-based analogues. 
To further verify that the CpFe(CO)2 moiety is essential for its anti-
proliferative properties and also for comparison purposes, several other 
structural and chemical modifications were made to the CpFe(CO)2 scaffold. 
With each newly modified complex, their cytotoxicity profile was investigated 
and compared against the ‘hit’ complexes identified in the previous chapter.  
3.2 Results and Discussion 
To compare the effect of the various organic isothiocyanates on the cancer cell 
lines, we started off by synthesizing a series of different isothiocyanates using 
a variety of literature methods. These experimental procedures and final 







Figure 3.1 The phase II enzyme induction system. (a) An isothiocyanate acts 
as an inducer by covalently modifying cysteine residues on the KEAP1 protein. 
This causes (b) the signalling molecule Nrf2 to dissociate and (c) translocate 
into the nucleus. In the nucleus, it associates (d) with the antioxidant response 
element (ARE) to (e) initiate production of phase II enzymes. 
 
3.2.1 Chemistry of Isothiocyanates  
As illustrated in Schemes 3.1 to 3.3, there are several methods to synthesize 
isothiocyanates starting from different precursors. In Scheme 3.1 a carboxylic 
acid is first converted to the acid chloride intermediate via a DMF catalysed 
halogenation reaction with oxalyl chloride. Subsequent reaction with solid 
potassium thiocyanate yields the final acyl isothiocyanate. This method also 





data of the IR-active NCS functionality. Typically an isothiocyanate functional 
group produces a broader infrared absorption band and at lower frequency as 
compared to the thiocyanate functional group which appears as a sharp band 
(Figure 3.2). The broader infrared band commonly observed with the 
isothiocyanate functional group is due to the overlapping of the C=N stretch 
and the first overtone of the C=N stretch. This gives the appearance of a broad 
band which may also sometimes appear as a shoulder.  
 






Scheme 3.2 Synthetic route for synthesising allylic isothiocyanates
 
Scheme 3.3 Synthetic route for synthesising aliphatic isothiocyanates 
 
The method employed in Scheme 3.2 involves the nucleophilic displacement 
of an allylic or tertiary alkyl halide using silver thiocyanate in a non-polar 
solvent. This method yields exclusively the isothiocyanate isomer as the use of 
the AgSCN favours the attack from the nitrogen rather than the sulfur due to 
strong association of the soft silver with the sulfur atom. This exposes the 
nitrogen atom and allows an N-attack on the electrophile, leading to the 
formation of only the isothiocyanate isomer. To confirm this hypothesis, 
experiments were performed with potassium thiocyanate (KSCN) and it was 
observed that only the thiocyanate isomer was obtained exclusively as 





The third method of synthesising isothiocyanates (Scheme 3.3) employs a 
direct nucleophilic attack of a primary or secondary amine on the electrophilic 
carbon disulfide, CS2, under low temperatures in the presence of an organic 
base such as triethylamine as a catalyst. Subsequent decomposition of the 
dithiocarbamate salt using hydrogen peroxide yields the isothiocyanate in 
good yields after purification through a silica column.  
 
Figure 3.2 Comparison of the shape and infrared absorption frequency of the 
ethyl thiocyanate (left) and allyl isothiocyanate (right) functionality 
 
The chemical structure of some of the isothiocyanates was confirmed via X-
ray single crystal diffraction of the thiourea derivatives (Figure 3.3). The X-
ray structure of the acyl isothiocyanate derivative has shown that the acid 
chloride intermediate undergoes an attack by the nitrogen of the NCS 
nucleophile and not the sulfur atom. The crystal structure of the sterically 
hindered triphenyl isothiocyanate also shows the presence of a C-N bonding 





































Figure 3.3 X-ray crystal structure of thiourea derivative of hexanoyl 
isothiocyanate with thermal ellipsoids at 50% probability 
 
Figure 3.4 X-ray crystal structure of triphenyl isothiocyanate with thermal 
ellipsoids at 50% probability 
 
3.2.2 Biological Studies of Organic Isothiocyanates  
The in vitro anti-cancer activity of the 21 organic isothiocyanates was 
evaluated against the human ER– breast carcinoma (MDA-MB-231) and 
normal breast epithelial cell line (MCF-10A) using the MTT [3-[4,5-
dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide or thiazolyl blue] 





the control in the experiment. The MTT assay results of the 19 isothiocyanates 
are tabulated in Figure 3.5. 
 
Figure 3.5 Effect of 40 M of isothiocyanate 1-21 on cell viability for the 
MDA-MB-231 cell line as determined by the MTT assay. Six isothiocyanates 
have been identified to possess anti-proliferative properties towards the breast 
carcinoma and are sorted into two groups according to their efficacy - blue 
(moderate activity) and red (good activity). Values have been normalized to 
DMSO treated cells. 
 
The MTT assay results in Figure 3.5 suggest that the 10 acyl isothiocyanates 
were ineffective as phase II enzymes inducers since the breast carcinoma were 
still viable after 24 hours incubation. However, replacing the carbonyl moiety 
by a methylene group increased the potency against the cell line, as 
exemplified by compounds 11-13, 15, 16, and 19. The difference in potency 
can be attributed to the increased reactivity of the isothiocyanate as a result of 
the neighbouring electron withdrawing carbonyl moiety. The increased 
electrophilic character of the central carbon in the isothiocyanate (N=C=S) 
moiety would favour addition reaction with any nucleophilic amines or thiols 






















thiocarbamate and rendering it inefficient at phase II enzyme induction. Hence, 
by moving this electron withdrawing group away, an increase in the potency 
of the isothiocyanate towards the carcinoma cells is to be expected. This 
observation is supported by prior studies [71, 73] that have concluded that a 
polar group such as sulfoxide or ketone group about four carbons away 
(regardless of orientation) would be ideal for the isothiocyanate to exhibit 
good potency towards cancer cells.  
For isothiocyanates 14 and 21, it is postulated that the steric bulk of the 
multiple phenyl substituents is hindering the interaction of the isothiocyanate 
functionality with the protein of interest, in this case the KEAP1 protein 
(Figure 3.1). This results in the isothiocyanate unable to induce the production 
of phase II enzymes, and hence little of no cell death was observed. 
Isothiocyanates 17, 18 and 20 share a common property. They all possess 
reasonably good water solubility since they are derived from dopamine, 
glucosamine and glutamine respectively. This increased solubility in aqueous 
media might have led to unwanted hydrolytic reactions that can render the 
isothiocyanate functional group inactive during the cell treatment, thereby 
explaining the lack of cytotoxicity towards the MDA-MB-231 cell line. 
The six organic isothiocyanates with moderate to good (blue and red in Figure 
3.5) anti-cancer activity identified from the MTT assay is then evaluated 
against the normal mammary cell line MCF-10A. The results from the MTT 
assay indicates that only the allyl isothiocyanates 11-13 (which are found 
naturally in broccolis) are relatively benign towards the normal breast cells. 





cells, killing more than half of the cell population at 40 M concentration 
(Figure 3.6). 
 
Figure 3.6 Effect of 40 M of the six potential isothiocyanates on cell 
viability for the MCF-10A normal mammary cell line as determined by the 
MTT assay. Values have been normalized to DMSO. 
 
Evidently, the organic isothiocyanates 15, 16 and 19 do not appear to be good 
candidates as potential anti-cancer agents. In addition, compounds 11-13 have 
already been extensively studied by Professor Talalay’s group and hence their 
effects on cancer and normal cells are already well-known and hence were 
used in the study as positive controls to allow for comparison of the potency of 
the newly synthesized isothiocyanates. 
Comparing with the CpFe(CO)2X class of transition metal carbonyl complexes 
in Chapter 2, these organic isothiocyanates anti-cancer activity are certainly on 
par with their transition metal analogues. However, further studies with these 
organic isothiocyanates on normal mammary cell lines showed that they have 
considerable toxicity which is not a characteristic of an ideal drug (Figure 3.7).  
The IC50 values against the normal mammary cells range is 18 M for 15 and  






















isothiocyanate sulforaphane (IC50 = 40 M against MCF-12A [204]). 
Therefore, it can be concluded that even though these organic isothiocyanates 
are sufficiently potent against breast cancer cell line, they unfortunately are 
not as benign as the transition metal analogues. 
 
Figure 3.7 Dose response curve of isothiocyanate 15 and 16 on MCF-10A 
normal cell line 
 
3.2.3 Structural Modifications to the CpFe(CO)2 Moiety 
To further validate the importance of the CpFe(CO)2 moiety in imparting the 
transition metal carbonyl with anti-cancer properties, the structure of the 
CpFe(CO)2 were modified in parts and the resulting complex evaluated again 
against the MDA-MB-231 cell line. 
 
Figure 3.8 Possible chemical modifications made to the CpFe(CO)2 moiety.  
Each part of the complex is modified one at a time to generate new complexes. 
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From Figure 3.8, it is possible to render four different types of chemical 
modifications to the CpFe(CO)2 moiety to achieve a new set of transition 
metal complexes. In the case of substituent X, the effect of these changes have 
been discussed in Chapter 2 and hence would not be considered in this section. 
These chemical changes are outlined in the table below. 
Table 3.1 Chemical modifications to CpFe(CO)2  moiety 
Type of Modification Structure of Complex 
Cyclopentadienyl  Allyl 22 
 





Iron  Cobalt 25-31 
 







For complexes 25-31, the various combinations of the axial ligands are 
tabulated below in Table 3.2. 
Table 3.2 Axial ligands and R groups on cobalt based complexes.dmgH = 
dimethylglyoxime; dpgH = diphenylglyoxime. 
Complex X Y R 
25 Cl Cl dmgH 
26 CH3COO CH3COO dmgH 
27 SCN SCN dmgH 
28 Cl Pyridine dpgH 
29 Cl Aniline dmgH 
30 SCN Pyridine dpgH 
31 SCN Pyridine dmgH 
 
 
Figure 3.9 X-ray Crystal Structure of Co(dpgH)(pyridine)Cl, 28, with thermal 






Figure 3.10 X-ray Crystal Structure of Co(dpgH)(pyridine)SCN, 30, with 
thermal ellipsoids shown at 50% probability.  
 
Figure 3.11 Cell viability study of the modified CpFe(CO)2 transition metal 
complexes 22-27 on MDA-MB-231 cell line. The cells were treated with the 
40 M of complexes for 24 hours at 37C and assayed using MTT. Red: 
























Figure 3.12 Cell viability study of modified CpFe(CO)2 transition metal 
complexes 22-27 on MCF-10A cell line. The cells were treated with the 40 
M of complexes for 24 hours at 37C and assayed using MTT. Red: 
Manganese complexes. Blue: Cobalt complexes. Black: Iron complexes 
 
3.2.4 Biological Analysis of the New Complexes after Modification 
The initial modifications were made and selected based on stability of the 
synthesized complex and the ease of synthesis. In addition, a few of the tested 
complexes were already commercially available and were used as the first step 
towards investigating the effect of changing the structure of the ‘hit’ 
compounds in Chapter 2 on the potency of the complex. Hence, if a transition 
metal complex performs poorly during cytotoxic evaluation, it would not be 
subjected to further biological analysis such as confocal microscopy and flow 
cytometry. The initial MTT data summarized in Figure 3.11 and 3.12 allows 
the following conclusions to be derived: 
1. As illustrated by complex 22, replacing the cyclopentadienyl ring with 
an allyl ligand does not considerably improve the potency against the 
cancer cell line MDA-MB-231. Despite this, an increased cytotoxic 






















2. Changing the metal to manganese (23 and 24) also does not appear to 
grant additional cytotoxicity towards the cancer cells but instead 
increases the cytotoxicity towards the normal mammary cell line.  
3. The cobalt based complexes 25-31 (which structurally resembles that 
of the vitamin B12 cobalamin) are not significantly cytotoxic towards 
cancer cells and also hardly kills the normal mammary cells at 40 M 
concentrations regardless of which axial ligands were used. 
Furthermore, a change of the planar dimethylglyoxime bidendate 
ligand to the sterically bulky diphenylglyoxime did not confer 
additional chemical toxicity towards both the normal and cancer cell 
lines. 
4. At first glance, 32 looks structurally similar to that of the ‘hit’ 
compound CpFe(CO)2I minus one carbonyl ligand. This modification 
however, reduces the toxicity of the complex based on the MTT assay 
data (a rise in cell viability from 56% to 90%) even though it left the 
normal cell line unscathed. This difference is hypothesized to be 
attributed to the long amine chain which might interfere with the 
Fenton redox reactions by sterically preventing incoming radicals from 
interacting with the iron centre. 
3.3 Conclusion 
To sum up, structurally altering the CpFe(CO)2 have led to unpredictable 
changes to the cytotoxicity of the resulting complexes. Clearly without 
elucidating the mechanism of action of the ‘hit’ complexes in Chapter 2, it is 
difficult to make an informed decision on what type of chemical modification 





time maintain or even reduce the cytotoxic nature on the normal cell lines. 
Nonetheless, what is clear is that we do have several complexes such as the 
manganese based complexes 23 and 24 that appear to be promising (killing off 
nearly a third of the cancer cells) and could potentially be further researched 
and modified upon. 
3.4 Experimental  
3.4.1 Materials 
Cyclopentadienyl manganese tricarbonyl, manganese pentacarbonyl bromide, 
cobalt (II) acetate, cobalt (II) chloride, 1,6-diaminohexane, potassium 
thiocyanate, silver thiocyanate, triphenyl methanol, 5-amino-1-pentanol, 4-
amino-1-butanol 1-aminoanthracene, 8-hydroxyquinoline, pyridine, histidine, 
allyl bromide, cinnamyl bromide, crotyl bromide, isovaleric acid, undecanoic 
acid, 4-phenylbutyric acid, 6-phenylhexanoic acid, 2-methylbutyric acid, 
ketoprofen, 9-anthracenecarboxylic acid, indole acetic acid, 3-
pyridinecarbaldehyde, triethylamine, toluene, methanol, ethanol, hexane and 
chloroform were purchased from Sigma-Aldrich. glucosamine hydrochloride, 
glutamine hydrochloride, dopamine hydrochloride, carbon disulfide, hydrogen 
peroxide, sodium hydroxide and 3-methoxycinnamic acid were purchased 
from Alfa Aesar. DMSO-d6, acetone-d6, methanol-d4, D2O, CDCl3 was 
purchased from Cambridge Isotopes. Penicillin-Streptomycin was obtained 
from GIBCO laboratories. Thiazolyl blue (MTT) was obtained from Promega. 
10 Phosphate Buffered Saline (PBS) pH 7.4, Dulbecco's Modified Eagle's 
Medium (DMEM) Fetal Bovine Serum (FBS) were purchased from Thermo 





a Milli-Q UV purification system (Sartorius Stedim Biotech SA, Aubagne 
Cedex, France). Annexin V/PI cell viability assay stains were purchased from 
Life Technologies. The MDA-MB-231 and MCF-10A cell lines were received 
with appreciation from Professor Paul Ho from the Department of Pharmacy, 
National University of Singapore and Professor Leong from School of 
Physical and Chemical Sciences, National Technological University. All 
chemicals were used without further purification. 
3.4.2 Solid State Structural Determination 
Single crystal X-ray structural studies were performed on Bruker-AXS Smart 
Apex CCD Single-Crystal Diffractometers by CMMAC, National University 
of Singapore. Data were collected at 100(2) K using graphite-monochromated 
Mo Kα radiation (λ = 0.71073 Å). Data collection was evaluated using 
SMART CCD system and processed for Lorentz and polarisation effects using 
SAINT software and for absorption effects using SADABS software. 
Structural solution and refinement were then carried out using SHELXTL 
suite of programs. The structure was solved by direct methods. All H atoms 
were put at calculated positions using the riding model. 
3.4.3 Instrumentation and General Methods  
All manipulations for chemical synthesis were carried out using standard 
Schlenk techniques under a nitrogen atmosphere. Photochemical experiments 
were conducted with a Legrand broadband lamp (350 – 800 nm, 11 W). All 
infrared spectra were obtained with Shimadzu IR Prestige - 21 Fourier – 
transformed infrared spectrometer (1000 – 4000 cm-1, 1 cm-1 resolution, 16 
scans co–added for spectra averaging) using a 0.05 mm path – length CaF2 cell 





Finnigan MAT LCQ spectrometer. 1H and 13C NMR spectra were recorded 
using Bruker AMX 300 Fourier Transform Spectrometer operating at 300 
MHz for both proton and carbon nuclei at room temperature, using CDCl3 as 
solvent unless otherwise stated. The chemical shifts were referenced to 
tetramethylsilane and are reported in ppm. 
3.4.4 Cell Culture and Drug Treatment 
Both MDA-MB-231 and MCF-10A cell lines were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM, Grand Island, NY, USA) supplemented 
with 10% fetal bovine serum (FBS), 1% l-glutamate (GIBCO Laboratories), 
and 1% penicillin/streptomycin (GIBCO Laboratories) at 37C in 5% CO2 
atmosphere. Compounds 1-32 were dissolved in DMSO and diluted until the 
final concentration used for incubation were 40 M. The treatment of the cells 
was performed by seeding the cells in DMEM growth medium at the same 
initial density. They were incubated for 24 hours to allow adhesion and growth 
before treatment (80% confluence). The cells were washed once with PBS and 
then treated with 40 M of the compounds 1-32 in DMEM. Control cells were 
treated with 0.1% DMSO. All cell lines were treated in the same manner. All 
final DMSO concentrations are at 0.1%. 
3.4.5 MTT Proliferation Assay 
The anti-proliferation activity of the various organic isothiocyanates and metal 
complexes were determined using MTT assay. Approximately 10,000 cells per 
well were seeded in a 96-well plate and allowed to adhere for approximately 
24 hours at 37C. The cells were then treated with 40 M of the compounds in 





CO2. The final concentration of DMSO in the medium was 0.1% (v/v). 
Following treatment, the media was removed and each well washed with 100 
L of PBS, followed by 100 L of MTT, (0.5mg/mL) in media and incubated 
for an additional 2 hours. After the incubation period, the MTT was removed 
and 100 L of DMSO was added to dissolve the formazan crystals. The 
absorbance intensities at 470 nm were then measured and cell viabilities 
relative to the control (DMSO) were calculated. The experiments were 
performed in triplicates for each concentration and three independent 
experiments were performed. 
3.4.6 Synthesis of Acyl Isothiocyanates 1-10 
1 mole equivalent of both the carboxylic acid and oxalyl chloride was 
dissolved in dichloromethane and the solution stirred under an atmosphere of 
nitrogen at room temperature. 2 drops of DMF as a catalyst was added after 
the addition of both the reactants. Upon addition of the catalytic DMF, brisk 
effervescence was observed and the reaction mixture turned yellow. The 
reaction was monitored by TLC and is typically completed within two hours 
or when evolution of the gaseous by-products has ceased. The product is then 
used immediately in the next step. 
Potassium thiocyanate (1 mole equivalent based on the carboxylic acid) was 
dissolved in 5 mL of acetone. This was then added dropwise to the freshly 
prepared acid chloride in the previous step. The mixture was then warmed 
gently for 2 hours during which a white precipitate of potassium chloride is 
observed. The salt was then was filtered after the reaction is completed and the 





evaporation followed by drying in a high vacuum. The acyl isothiocyanates 
were then analysed via infrared spectroscopy (for the presence of the NCS 
functional group) and 1H NMR. 
1: The product was obtained as a light yellow liquid after vacuum drying. 1H 
NMR (CDCl3, ppm): 2.35-2.46 (m, 1H, 
3J = 6 Hz), 1.64-1.79 (m, 1H, 3J = 6 
Hz), 1.38-1.57 (m, 1H, 3J = 6 Hz), 1.18 (d, 3H, 3J = 6 Hz), 0.95 (t, 3H, 3J = 6 
Hz). IR (acetone, max, cm−1): 1977 (SC=N). 
2: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 76%. 1H NMR (CDCl3, ppm): 5.83-5.96 (m, 1H), 5.09-5.17 (m, 2H), 
2.27-2.32 (m, 2H), 2.07-2.09 (m, 2H), 1.02-1.39 (m, 12H). IR (hexane, max, 
cm−1): 1972 (SC=N), 1741 (C=O). 
3: The product was obtained as an oily liquid. Yield: 70%. 1H NMR (CDCl3, 
ppm): 5.83-5.96 (m, 1H, 3J = 6 Hz), 5.09-5.17 (t, 2H, 3J = 15 Hz), 2.29 (t, 2H 
3J = 7.5 Hz), 2.09 (t, 2H, 3J = 6 Hz), 1.02-1.39 (m, 12H). IR (acetone, max, 
cm−1): 1981 (SC=N),  
4: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 54%. 1H NMR (benzene-d6, ppm): 2.07 (t, 2H, 
3J = 7.5 Hz), 1.15-1.49 
(m, 29H), 0.91 (t, 3H, 3J = 6Hz). (IR (hexane, max, cm−1): 1979 (SC=N). 1740 
(C=O). 
5: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 60%. 1H NMR (CD2Cl2, ppm): 2.86-2.90 (t, 2H), 1.68-1.71 (m, 2H), 





6: The product was obtained as deep yellow oil after rotary evaporation. Yield: 
52%. 1H NMR (CDCl3, ppm): 7.53-7.81 (m, 9H), 4.02-4.09 (q, 1H), 2.51-2.53 
(d, 3H). IR (acetone, max, cm−1): 1970 (SC=N). 
7: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 66%. 1H NMR (CDCl3, ppm): 7.17-7.32 (m, 5H, 
3J = 7.5 Hz), 2.68 (t, 
2H, 3J = 9 Hz), 2.38 (t, 2H, 3J = 7.5 Hz), 1.97 (m, 2H, 3J = 7.5 Hz). IR (ethyl 
acetate, max, cm−1): 1977 (SC=N). 
8: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 86%. 1H NMR (CDCl3, ppm): 7.73-7.79 (d, 1H, 
3J = 18 Hz), 7.32 (t, 1H, 
3J = 7.5 Hz), 7.15 (d, 1H, 3J = 6 Hz), 7.07 (t, 1H, 3J = 6 Hz), 6.98 (dd, 1H, 3J = 
6 Hz), 6.42-6.47 (d, 1H, 3J = 15 Hz), 3.85 (s, 3H). IR (acetone, max, cm−1): 
1967 (C=N). 
9: The product was obtained as a light yellow viscous liquid after vacuum 
drying. Yield: 67%. IR (acetone, max, cm−1): 1976 (SC=N). 
10: The product was obtained as a light yellow liquid after vacuum drying. 
Yield: 62%. 1H NMR (CD3CN, ppm): 6.92-.6.94 (d, 1H), 6.77-6.8-0 (d, 1H), 
6.66 (d, 1H), 6.39-6.53 (dt, 2H), 3.07 (s, 2H). IR (acetone, max, cm−1): 1977 
(SC=N). 
3.4.7 Synthesis of Isothiocyanates 11-14 
1 equivalent of the organic allylic or alkyl halide is dissolved in toluene and 2 
equivalents of silver thiocyanate were added as a suspension in toluene. The 





hours to yield exclusively the isothiocyanate isomer as confirmed via infrared 
spectroscopy. The thiocyanate linkage isomer was not obtained. 
11: The compound was obtained as a yellow viscous liquid and is sufficiently 
pure as ascertained from TLC and NMR without the need for purification. 
Yield: 92%. 1H NMR (toluene-d8, ppm): 7.34-7.37 (m, 5H), 6.64-6.73 (m, 1H), 
6.14-6.35 (m, 1H), 4.30-4.32 (m, 1H), 3.76-3.78 (m, 1H). IR (toluene, max, 
cm−1): 2086 br (SC=N). 
12: The compound was obtained as a yellow viscous liquid and is sufficiently 
pure as ascertained from TLC and NMR without the need for purification. 
Yield: 88%. 1H NMR (CDCl3, ppm): 5.83-5.94 (m, 2H), 5.31-5.39 (m, 1H), 
3.52-3.55 (d, 3H, 3J = 9 Hz). IR (toluene, max, cm−1): 2058, 2093 (SC=N). 
13: The compound was obtained as a yellow viscous liquid and is sufficiently 
pure as ascertained from TLC and NMR without the need for purification. 
Yield: 75%. 1H NMR (toluene-d8, ppm): 5.04-5.15 (m, 1H), 4.74-4.95 (m, 2H), 
3.05-3.08 (dt, 2H). IR (toluene, max, cm−1): 2097, 2164 (SC=N). 
14: The compound was obtained as colourless crystals upon recrystallization 
from acetone. Yield: 93%. IR (acetone, max, cm−1): 2059, 2125, 2551 (SC=N). 
3.4.8 Synthesis of Isothiocyanates 15-21 
1 equivalent of amine in THF was mixed with 5 equivalents of triethylamine 
and cooled in an ice bath. Five equivalent of carbon disulfide was added 
dropwise into the mixture with stirring. The reaction flask was removed from 
the ice bath after addition of the carbon disulfide is completed and allowed to 





thiocarbamate salt was then effected via the addition of two equivalent of 
hydrogen peroxide. The resulting mixture was then stirred for another 30 
minutes before adding concentrated hydrochloric acid to remove the excess 
trimethylamine. The isothiocyanate was then extracted twice using ethyl 
acetate after which the solvent was removed under vacuum and the resulting 
solution extracted with ethyl acetate. The crude product was then purified via 
column chromatography using 1:1 ethyl acetate-hexane as eluent. 
15: The compound was obtained as a light yellow liquid and is sufficiently 
pure as ascertained from TLC and NMR without the need for purification. 
Yield: 64%. 1H NMR (CDCl3, ppm): 3.66 (t, 2H, 
3J = 7.5 Hz), 3.53 (t, 2H, 3J = 
7.5 Hz), 1.46-1.75 (m, 6H, 3J = 6 Hz). IR (ethyl acetate, max, cm−1): 2106, 
2186 (SC=N) 
16: The compound was obtained as a light yellow viscous liquid and is 
sufficiently pure as ascertained from TLC and NMR without the need for 
purification. Yield: 71%. 1H NMR (CDCl3, ppm): 3.48 (t, 2H, 
3J = 6 Hz), 2.65 
(t, 2H, 3J = 7.5 Hz), 1.46 (m, 2H, 3J = 7.5 Hz) IR (ethyl acetate, max, cm−1): 
2107, 2184 (SC=N). 
17: The compound was obtained as a colourless liquid and is sufficiently pure 
as ascertained from TLC and NMR without the need for purification. Yield: 
66%. 1H NMR (CD3OD, ppm): 6.72-6.79 (dd, 2H, 
3J = 9 Hz), 6.60-6.63 (dd, 
1H, 3J = 6 Hz) 3.14 (t, 2H, 3J = 6 Hz), 2.83 (t, 2H, 3J = 6 Hz). IR (ethanol, max, 
cm−1): 2100, 2183 (SC=N). 
18: The compound was obtained as a colourless viscous liquid and is 





purification. Yield: 56%. 1H NMR (D2O, ppm): 5.44-5.45 (d 1H, 
3J = 3 Hz), 
3.79-3.93 (m, 4H), 3.48 (t, 1H, 3J = 9 Hz), 3.27-3.32 (dd, 1H, 3J = 10.5 Hz). IR 
(THF, νmax, cm−1): 2159, 2171 (SC=N). 
19: The compound was obtained as a light yellow viscous liquid and is 
sufficiently pure as ascertained from TLC and NMR without the need for 
purification. Yield: 64%. 1H NMR (CDCl3, ppm): 2.67 (t, 4H, 
3J = 7.5 Hz), 
1.29-1.45 (m, 8H, 3J = 6 Hz). IR (ethyl acetate, max, cm−1): 2105, 2177 
(SC=N). 
20: The compound was obtained as a pale yellow liquid and is sufficiently 
pure as ascertained from TLC and NMR without the need for purification. 
Yield: 52%. 1H NMR (D2O, ppm): 3.86 (t, 1H, 
3J = 6 Hz), 2.52-2.57 (dt, 2H, 
3J = 7.5 Hz), 2.19-2.26 (q, 2H, 3J = 7.5 Hz). IR (THF, max, cm−1): 2156, 2167 
(SC=N). 
21: The compound was obtained as yellow oil and is sufficiently pure as 
ascertained from TLC and NMR without the need for purification. Yield: 76%. 
IR (ethyl acetate, max, cm−1): 2093, 2121 (SC=N). 
3.4.9 Synthesis of 22, 3-C3H5Fe(CO)3Br 
Three molar equivalents of allyl bromide were mixed with 1 molar equivalent 
of iron carbonyl in hexane. The hexane solution was then refluxed under 
nitrogen and the reaction monitored via infrared spectroscopy until the starting 
material carbonyl absorption bands completely disappeared. The reaction 
mixture was then purified via column chromatography using 1:1 hexane:ethyl 





vacuum in a desiccator. Yield: 58%. IR (hexane, max, cm-1): 2016, 2047, 2090 
(C=O). 
3.4.10 Synthesis of 25, Co(dmgH)2Cl2 
2.2 mole equivalent of dimethylglyoxime was added to a stirred solution of 1 
mole equivalent cobalt (II) chloride hydrate in 10 mL of acetone. A gentle 
stream of air was passed into the solution from which a green solid was slowly 
deposited. The reaction was then allowed to continue to stir over 1 hour. 
Subsequently, the reaction mixture was chilled on ice, filtered, and washed 
with 2 x 10 mL of cold acetone. The green crystalline product was then 
collected and dried under vacuum in a desiccator. Yield: 70%. 
3.4.11 Synthesis of 26, Co(dmgH)2(CH3COO)2 
2.2 mole equivalent of dimethylglyoxime was added to a stirred solution of 1 
mole equivalent cobalt (II) acetate hydrate in 10 mL of acetone. A gentle 
stream of air was then passed into the solution from which a green solid was 
slowly deposited. The reaction was then allowed to continue to stir over 1 hour. 
Subsequently, the reaction mixture was chilled on ice, filtered, and washed 
with 2  10 mL of cold acetone. The green crystalline product was then 
collected and dried under vacuum in a desiccator. Yield: 80%. 
3.4.12 Synthesis of 27, Co(dmgH)2(SCN)2 
1 mole equivalent of potassium thiocyanate was dissolved in acetone and 1 
mole equivalent of cobalt chloride was added. The blue solution was stirred at 
room temperature for 2 h, and filtered to remove the white potassium chloride 





product, Co(NCS)2. Yield: 65%. IR (dimethylformamide, max, cm−1): 2075 
(SC=N). 
1 mole equivalent of the cobalt (II) thiocyanate salt from the previous step was 
dissolved in 10 mL of acetone and then added to 2.2 mole equivalent of 
dimethylglyoxime. The reaction mixture was stirred at room temperature for 
3.5 hours in the presence of air. A brown solid slowly deposited and is 
collected via suction filtration at the end of the 3.5 hours. The solid was 
washed with 2  10 mL cold acetone and dried under vacuum in a desiccator. 
Yield: 67%.IR (dimethylformamide, max, cm−1): 2109 (SC=N). 
3.4.13 Synthesis of 28, Co(dpgH)2(pyridine)Cl 
2.2 mole equivalent of diphenylglyoxime was added to a stirred solution of 1 
mole equivalent cobalt (II) chloride hydrate in 10 mL of acetone. A gentle 
stream of air was passed into the solution from which a green solid was slowly 
deposited. The reaction was then allowed to continue to stir over 1 hour. 
Subsequently, the reaction mixture was chilled on ice, filtered, and washed 
with 2 x 10 mL of cold acetone. The green crystalline product was then 
collected and dried under vacuum in a desiccator. Yield: 70%. 
1 mole equivalent of the above Co(dpgH)2Cl2 is suspended in 10 mL of 
methanol. 2.2 mole equivalents of pyridine were then added with stirring. The 
agitation was continued until the green solid disappears and is replaced by a 
brown crystalline solid over about 20 to 30 minutes. 20 mL of deionised water 
was then added with stirring and the brown suspension was then cooled in ice 





wash with 3  10 mL of 2:1 water/methanol and 2  10 mL of diethyl ether. 
Yield: 68%. 
3.4.14 Synthesis of 29, Co(dmgH)2(NH2Ph)Cl 
1 mole equivalent of complex 25 was suspended in 10 mL of methanol and 
aniline slowly added with stirring in air at room temperature for 1 h. The 
initial yellow solution turned red upon aniline addition. The crude product was 
filtered to remove insoluble solids and the filtrate was column 
chromatographed on silica gel eluting with 100% ethyl acetate. Yield: 63%. 
ES-MS (+ve mode): m/z = 416.0 [M-H]-. Anal. calcd. for C14H21ClCoN5O4: 
(%): C 40.25, H 5.07, N 16.77; found: C 44.36, H 5.21, N 14.81. 
3.4.15 Synthesis of 30, Co(dpgH)2(pyridine)(SCN) 
1 molar equivalent of potassium thiocyanate was dissolved in acetone and 1 
mole equivalent of cobalt chloride was added. The blue solution was stirred at 
room temperature for 2 h, and filtered to remove the white potassium chloride 
precipitate. The filtrate was then removed via rotary evaporation to obtain the 
product, Co(NCS)2. Yield: 77%. IR (dimethylformamide, max, cm−1): 2075 
(SC=N). 
1 mole equivalent of the cobalt (II) thiocyanate salt from the previous step was 
dissolved in 10 mL of acetone and then added to 2.2 mole equivalent of 
diphenylglyoxime. The reaction mixture was stirred at room temperature for 
3.5 hours in the presence of air. A brown solid slowly deposited and is 
collected via suction filtration at the end of the 3.5 hours. The solid was 
washed with 2  10 mL cold acetone and dried under vacuum in a desiccator. 





1 molar equivalent of the product from the previous step was then suspended 
in 25 mL of methanol and 2 equivalents of pyridine were added. The mixture 
was stirred at room temperature for 1 hour. Subsequently, 25 mL of water was 
added and the entire reaction mixture cooled in an ice bath for 10 minutes. A 
dark orange solid precipitated and was collected via suction filtration. The 
solid was washed with 2:1 water/methanol, followed by diethyl ether, and air 
dried to give the titled product. Yield: 52%. IR (dimethylformamide, max, 
cm−1): 2114 (SC=N). 
3.4.16 Synthesis of 31, Co(dmgH)2(pyridine)(NCS) 
1 mole equivalent of the 27 was dissolved in 10 mL of acetone and then added 
to 2 equivalents of pyridine. The reaction mixture was stirred at room 
temperature for 1 hour. 40 mL of water was then added with stirring, and the 
suspension was cooled in an ice bath for 10 min. The precipitated product was 
collected via suction filtration, washed with 2:1 water/methanol, followed by 
diethyl ether, and air dried to give an orange product. Yield: 54%. IR 
(dimethylformamide, max, cm−1): 2113 (SC=N). ESI-MS (m/z): 424.7 [M-H]-.  
Anal. calcd. for C14H19CoN6O4S: (%): C 39.44, H 4.49, N 19.71, S 7.52; 
found: C 39.84, H 4.88, N 16.91, S 6.23 
3.4.17 Synthesis of 32, CpFe(CO)(NH2(CH2)6(NH2)I 
1 equivalent of CpFe(CO)2I was dissolved in DMSO and 2 molar equivalent 
of 1,6-diaminohexane was added. The mixture was stirred for 24 hours under 
nitrogen at room temperature to obtain a yellowish-orange solution containing 
32. The DMSO was distilled off and an orange solid was obtained. Yield: 71%. 









Chapter 4 Transition Metal Carbonyls as 
CO and H2S Releasing Molecules 
Transition Metal Carbonyls as CO- and 
H2S- Releasing Molecules 
 
 
4.1 Introduction  
Carbon monoxide, CO has been shown to play a vital role as a low 
concentration cell-signalling molecule in living organisms [10, 94, 205]. In the 
body, it has been identified that the endogenous CO is produced by the gene 
HO1 via the catalysis of haem, with the production rate estimated at 0.006 mL 
per hour per kg of body weight. However as many factors can alter the 
production rate of CO, a reliable estimation of its physiological concentration 
is not possible. Nonetheless, experiments performed using known quantities of 
CO have put the therapeutic dosage in the nanomolar range [206]. In the past 





gene are more prone to diabetes, atherosclerosis, chronic obstructive 
pulmonary disease and arthritis [207-210] indicating that CO have indeed an 
essential role to play. These physiological properties of CO have been well–
studied and in the last decade, carbon monoxide-releasing molecules known as 
CORMs have been used to release CO [211, 212]. The molecules used are 
mainly transition metal carbonyls such as Mn2(CO)10, [Ru(CO)3Cl2]2 and 
Ru(CO)3Cl(glycinate) [10, 213]. The CO release can be activated or triggered 
photochemically or thermally. The Ru(CO)3Cl(glycinate) complex, one of the 
first water soluble CO-RM to be synthesized, readily loses CO at room 
temperature and hence is not a reliable source of CO since the release cannot 
be controlled. An iron dienylphosphate tricarbonyl complex is also known to 
release CO upon interaction with an enzyme [214]. 
If light has been used to trigger CO release from a molecule, the molecule is 
known as a photoCORM [215, 216]. While many metal carbonyl complexes 
which release CO upon UV irradiation are known, it is only recently that 
efficient visible light-initiated photoCORMs are described in literature, such 
as manganese carbonyl scorpionates [217] and iron carbonyls containing 
cysteamine ligands [218, 219]. 
A suitable photoCORM for use in biological systems has to satisfy many 
criteria such as water solubility, molecular stability, ability to release CO 
quickly upon mild visible-light irradiation and able to form water-soluble final 
products to prevent clogging the arteries. In this chapter, a water-soluble 
dithiolate-bridged diiron complex using 3-mercaptopropanoate as the bridging 





analogous diiron complexes have already been extensively studied as [Fe-Fe] 
hydrogenase model compounds in reducing protons to dihydrogen [220, 221], 
this complex can also act as an efficient photoCORM by releasing CO within 
30 minutes of broadband visible light irradiation. Instead of monitoring the 
changes in UV of myoglobin for CO quantification, the concentration of CO 
released into the headspace of the photolytic mixture is determined directly 
using gas-phase FTIR spectroscopy.  
Another gasotransmitter that has become an area of research interest is the 
noxious gas, hydrogen sulfide (H2S). Commonly formed by commensal 
bacteria, research has shown that the gas is a biologically important signalling 
molecule involving in a myriad of cellular processes such as muscle relaxation 
[222], neuromodulation [13, 223, 224], blood pressure regulation and insulin 
release [225, 226]. H2S has also been found to exhibit anti-cancer effects in 
both in vivo and in vitro studies. In mammalian tissues, H2S is synthesized 
from L-cysteine via cystathionine--synthase (CBS) and cystathionine--lyase 
(CSE) enzymes. The role of hydrogen sulfide as a small messenger molecule 
mirrors that of NO as both transmit information via the modification of 
sulfhydryl groups on the cysteine residues of their respective target proteins. 
In the case of H2S, this modification is termed protein sulfhydration. 
To date, however, H2S-releasing molecules have been limited to light-
activated organic dithiolate compounds such as N-(benzoylthio)benzamide and 
persulfide-based derivatives [227], simple organic sulfides such as diallyl 
disulfide and diallyl trisulfide [228] or inorganic salts, such as sodium 





manner under aqueous conditions while endogenous H2S is produced at a 
much slower rate and at a lower concentration of less than 500 nM [229]. 
Hence, NaSH does not accurately mimic the effects of naturally-produced 
endogenous H2S. Not only that, research progress with H2S is impeded by the 
reactivity of free gaseous H2S with atmospheric oxygen forming different 
oxidative products and rendering the storage, manipulation and production of 
the gas particularly challenging. In addition, inhalation as a delivery option is 
also not viable. If H2S is not suitably administered, the gas causes not only 
nausea and irritation of the mucus lining but is also potentially lethal [230]. To 
circumvent this problem, the search for water-soluble molecules that can 
release free hydrogen sulfide gas in a controlled fashion continues to be 
actively pursued by many research groups [11]. In this chapter, we will also 
report the synthesis and characterisation of a series of water-soluble Group VI 
transition metal carbonyl hydrosulfides capable of releasing free H2S in a 
controlled manner upon hydrolysis. 
Together, these CO- and H2S-releasing molecules make up a class of water 
soluble gasotransmitters releasing molecules that is non-toxic to living cells 
and has good bioavailability in terms of controlled release of the signalling 
molecules. 
4.2 Results and Discussion 
4.2.1 Chemistry of CO Releasing Molecules 
The orange diiron carbonyl complex containing 3-mercaptopropionic acid 
(MPA) as the bridging thiolate ligand, (µ-MPA)2[Fe(CO)3]2 (1) was prepared 





obtained for (µ-MPA)2[Fe(CO)3]2 in toluene as shown in Figure 4.1 are in 
excellent agreement with reported values for similar diiron dithiolato 
complexes [220]. ESI mass spectrometry carried out on the complex in ethanol 
shows an intense signal at m/z = 488.40 corresponding to its molecular ion 
peak. The UV-vis spectrum (Figure 4.1) recorded for the complex in acetone 
shows an intense band at max = 330 nm and a weaker band at max ≈ 460 nm. 
The absorption of the complex tails off at about 600 nm in the visible region. 
 
Figure 4.1 Infrared absorption (left) and UV-vis absorption spectrum of 1 
taken in toluene and acetone respectively. 
 
Single crystals of 1 obtained by slow evaporation of toluene were subjected to 
X-ray diffraction studies for structural determination (Figure 4.2). The 
complex crystallizes in the monoclinic space group P2(1)/n, with unit cell 
dimensions a = 7.794 Å, b = 25.126 Å, c = 9.179 Å,  = 97.415o. The overall 
structure resembles other previously-characterized thiolate-bridged diiron 
complexes [220]. The Fe(I) centre is coordinated to the sulfur end of MPA, 
thus freeing the carboxylic acid for further functionalization. In our case, a 
simple deprotonation of the acid groups is sufficient to render the complex 




































single Fe – Fe bond. The Fe-CO bonds almost parallel to the Fe-Fe bond are 
slightly longer (1.805 Å) than the other four Fe-CO bonds (1.794 Å). 
 
Figure 4.2 X-ray Crystal Structure of (µ-MPA)2[Fe(CO)3]2, 1, with thermal 
ellipsoids shown at 50% probability. MPA = 3-mercaptopropionic acid. 
The diiron complex is stable in the dark and can be made to dissolve 
completely in water upon deprotonation by sodium carbonate. The complex 
remains intact in water as a carboxylate salt Na2[(-SCH2CH2COO)Fe(CO)3]2, 
1·Na since the UV-vis spectrum of the complex recorded in water has the 





4.2.2 Quantification of CO Release from 1 
Although diiron complexes with bridging thiolate ligands have been known to 
release CO upon nucleophilic substitution, the reaction is slow at room 
temperature unless strong donors such as PMe3 are used [231]. Hence 1·Na 
has been subjected to broadband visible light irradiation in order to release the 
CO ligand. In previous studies, the quantification of CO was mostly carried 
out by measuring the conversion of deoxymyoglobin to CO-bound myoglobin 
via their respective UV-vis absorbance. This presents some problems during 
UV-vis measurements. One, the presence of coloured complexes caused a 
background that hinders UV-vis detection. Two, in the myoglobin assay, a 
strong reducing agent such as dithionite is required and in some cases, the 
dithionite interferes with the CO release from metal carbonyls [232]. Finally, 
the binding constant of CO to myoglobin needs to be larger than that to the 
CO-RM to ensure an accurate quantification. Therefore, another method of 
measuring the CO concentration in the absence of myoglobin would be useful 
since any CO release can easily be traced to the photo-dissociation of the 
complex and thus confirms its role as a photoCORM.  
The quantification of CO release is done by monitoring its gas-phase 
rovibrational spectrum in the headspace above the aqueous solution [233]. The 
headspace was directly connected to a 15cm-long gas cell equipped with CaF2 
windows for IR transmission. Since the solubility of CO in water is very low, 
most of the CO would be released into the headspace and gas cell hence 
minimising the error in determining its concentration. An added advantage is 
the CO quantification can be carried out in situ, without removing aliquots of 





tens of Torr, pressure broadening effects are small and hence do not affect the 
peak absorbances significantly. As the line strength of each rovibrational line 
has been determined accurately, the concentration of CO can be calculated 
directly using the following equation [234]:  
𝐴𝑡(𝑣) =
𝑆(𝑚) ∙ 𝐶 ∙ 𝐿
π ∙ γ(m) ∙ ln(10)
 
where At(ν) is the experimental absorbance, S(m) is the line strength (cm−2 
atm−1), C is the concentration (atm), L is the path length (cm), and γ(m) is the 
half-width of the line (cm−1). In this work, L = 15 cm and a few P (m = −J″) 
and R branch (m = J″ + 1) lines have been used to determine the average 
concentration of CO. For example, the S values for the intense P(7) and P(8) 
rovibrational lines are 11.367 and 11.241 cm−2 atm−1, respectively. 
In the experiments, the release of the CO was performed by irradiation of an 
aqueous solution containing 1·Na at room temperature. The gas-phase infrared 
absorption spectrum of CO is then monitored in the gas cell. By applying the 
equation, we found that each 1·Na releases all six CO ligands within 30 to 40 
minutes of broadband irradiation (Figure 4.3). In fact, CO signals can already 
be observed within a few minutes of irradiation. The release of the CO ligands 
from the complex is explained by the excitation of d electrons (t2g) from the 
metal to the * anti-bonding orbitals (t2u) in the CO ligand, leading to cleavage 
of the M-C bond. The UV-vis absorbance of the complex at max = 330 nm 
was also monitored and found to decrease rapidly also within the same period. 
The period of irradiation for which all CO are released depends on the easily 





quantification, the irradiation was fixed at a distance such that sufficient data 
points can be collected and repeated. The same results were obtained in both 
aerated and deaerated aqueous solutions, indicating that air or oxygen does not 
affect the CO release. 
The quantum yield of the initial photo-dissociation of 1·Na at 390 nm was 
estimated to be 0.4 ± 0.1 by comparison to CpMn(CO)3 photo-dissociation, 
which has a known quantum yield of near unity [235]. The wavelength of 390 
nm was chosen, as both complexes have moderate absorbances in this region. 
While the quantum yield may not be very high, the photo-dissociation of the 
diiron thiolate can still proceed equally efficiently in air or under vacuum. 
 
Figure 4.3 Change in the gas-phase CO quantity and UV-vis absorbance. The 
CO quantity is expressed as mole equivalent of 1·Na with respect to the period 
of irradiation detected using FTIR spectroscopy (dotted line). The change in 
the UV-vis absorbance of 1·Na against the irradiation period is shown as a 
dashed line 
 
We are unable to detect any intermediates during irradiation although stepwise 
release of CO from the complex is expected. Thiolate-bridge diiron complex is 





































a diiron tetracarbonyl species [236]. However in the absence of strong donors 
or nucleophiles, the intermediate complex or complexes most likely 
decompose quickly to release the remaining CO molecules. At the end of 
photolysis, the aqueous solution turns red without any observable deposits. 
The UV-vis spectrum of the red solution shows a small absorption band at 
max = 475 nm while the ESI spectrum taken of the solution in methanol shows 
a signal at m/e = 407 (negative mode) tentatively assigned to a 
Na3[Fe
III(SCH2CH2COO)3]-methanol  adduct.  
4.2.3 Biological and Cytotoxicity Studies of 1 
We have also carried out preliminary studies on the cytotoxicity of 1·Na 
towards mammary epithelial cells MCF-10A (Figure 4.4). Treatment of the 
cells using a range of diiron complex concentration from 1 to 40 M did not 
lead to any observable cytotoxicity within 24 hours, as determined via the 
MTT assay. In fact, we were unable to determine an IC50 value, since hardly 
any cell deaths occur over this range of concentration and time. Hence, even if 
the CO photo release period takes place in 1 hour, the diiron complex is 
expected to have minimal undesirable effect on the cells. 
 
Figure 4.4 Viability of mammary epithelial cells MCF-10A after 24 hours 
incubation with 1·Na, as determined by the MTT assay.Cell viabilities have 






















4.2.4 Chemistry of H2S-Releasing Molecules 
The Group 6 transition metal carbonyl hydrosulfide anionic complexes 
[M(CO)5SH]
- (M = Cr, Mo, W; Scheme  4.1) were prepared by a modification 
of a previously published procedure [237]. Briefly, a methanol solution 
containing the transition metal hexacarbonyl, M(CO)6 with sodium 
hydrosulfide (NaSH) was irradiated under a broadband UV source. The 
carbonyl infrared absorption bands obtained for the resulting complex 
suggests a pattern typical of C4v symmetry, albeit being red-shifted due to the 
negative charge on the metal complex (Figure 4.5). The UV-vis spectra of the 
complexes show broad absorption down to 600-700 nm. ESI mass 
spectrometry carried out on all three complexes shows the characteristic 
molecular ion signal, M- along with several signals corresponding to CO loss 
species. All three anions are also water-soluble. 
 
Scheme 4.1 Structures of the three Group 6 transition metal hydrosulfides 
anions 
Comparing the three metal hydrosulfides, the molybdenum complex 
Na[Mo(CO)5SH] appears to be most stable as a solid in air, hence it is chosen 
for more detailed studies. When dissolved in water or wet methanol, the 
complex slowly hydrolyses at room temperature, although the hydrolysis can 
be accelerated by the addition of strong acids. Regardless of the acid strength, 





characterised by its IR (Figure 4.5) and UV-vis (Figure 4.6) absorption 
spectra. Although the IR spectra of the product could not be obtained in water, 
comparison of the UV-vis spectrum of Mo(CO)5(MeOH) spectrum in 
methanol with that of the species formed after acidification suggests that  
Mo(CO)5(H2O) is the most likely product in aqueous solution [238].   
 
Figure 4.5 (left) Infrared spectrum of [Mo(CO)5SH]
- (red) and 
[Mo(CO)5(MeOH)] (black) taken in methanol. 
 
Figure 4.6 UV-vis spectrum of [Mo(CO)5SH]
- (red),  [Mo(CO)5(MeOH)]
- 
(black) in methanol and [Mo(CO)5(H2O)]





































4.2.5 Quantification Studies on the Hydrosulfides 
We have also used the changes in pH of an aqueous solution of NaSH as an 
indicator of H2S gas formation since pH is expected to increase due to the 
concomitant formation of sodium hydroxide;  
NaSH + H2O ⇌ NaOH + H2S 
The anion HS- is a very weak base as inferred from its pKa value of 7. Hence 
it readily hydrolyses in water to yield the conjugate acid. Evolution of the H2S, 
aided by the low solubility in aqueous medium further shifts the position of 
the equilibrium to the right in accordance with Le Chatelier’s Principle. Indeed, 
the pH of the solution was determined to be around 11 only a few minutes 
after NaSH hydrolysis in deionised water. The contribution of the sparingly-
soluble H2S gas to pH changes in water can be considered to be negligible due 
to its low solubility [239]. By inference metal hydrosulfides are expected to 
undergo a similar reaction with water; 
Na[Mo(CO)5SH] + H2O ⇌ NaOH + Mo(CO)5(H2O) + H2S 
However the pH increase is much slower and reaching similar pH values only 






Figure 4.7 Changes in pH upon hydrolysis of the Cr (black), Mo (red) and W 
(blue) hydrosulfides as monitored using pH meter over a period of one hour.  
 
The release of hydrogen sulfide gas from [Mo(CO)5SH]
- has been detected 
quantitatively via gas-phase infrared spectroscopy by monitoring its intense 
bending vibrational mode centred at 1180 cm-1 in the headspace above the 
aqueous solution. For the IR measurements, the headspace was directly 
connected to a 15cm-long gas cell equipped with CaF2 windows for IR 
transmission. Since the solubility of H2S in water is very low [239], most of 
the gas would be released into the headspace hence minimising the error in 
determining its concentration. This method also allows continuous monitoring 
of the gas in situ without the need to remove aliquots from the solution. The 
absorbance of the band is first calibrated by using a standard pressure of H2S 
generated stoichiometrically from the reaction of a strong acid on a known 
quantity of solid NaSH. Care is taken such that the absorbance is proportional 
to the concentration according to Beer’s law [9].  
As seen in Figure 4.8, the release of H2S occurs gradually over a period of 40 
minutes for Mo(CO)5SH















H2S production reaches a plateau close to one mole equivalent of the amount 
of Na[Mo(CO)5SH] present initially in the aqueous solution. Interestingly, no 
CO peak ( = 2143 cm-1) was detected which indicates that the acidification 
process only affects the SH- ligand. This result is also consistent with 
Mo(CO)5(H2O) being the major product since both reactant and product 
contain the same number of CO ligands. Thus Mo(CO)5SH
- acts purely as a 
H2S-releasing molecule and not as a CORM (CO-releasing molecule).  
 
Figure 4.8 Changes in IR absorbance of H2S release of Mo (red), Cr (black) 
and W (blue) vs time in a pH 6.5 phosphate buffer solution containing 0.005M 
of Na[M(CO)5SH]. 
 
From the results obtained via infrared and pH measurements, it can be 
proposed that the release of H2S from the three metal hydrosulfides follow the 
order Cr > Mo > W. According to rate of evolution of H2S as monitored via IR 
spectroscopy in Figure 4.8, the chromium complex releases H2S fully in 25 
minutes; the molybdenum complex requires 40 minutes and tungsten complex 
took more than an hour. The pH measurements in Figure 4.7 lend further 























4.2.6 Biological and Cytotoxicity Studies on the Metal Hydrosulfides 
If these metal complexes were to be used as H2S releasing agents in biological 
systems, then their cytotoxic profile have to be first established. Hence the 
anti-cancer and cytotoxic properties of Na[Mo(CO)5SH] towards MCF-10A 
mammary epithelial cells and well as MDA-MB-231 breast adenocarcinoma 
cells were next evaluated. Treatment of the cells with concentrations ranging 
from 1 M to 40 M of the molybdenum hydrosulfide on the normal 
mammary cells did not lead to any observable cytotoxicity over a period of 24 
hours, as concluded from the MTT assay (Figure 4.9). Interestingly, 
Na[Mo(CO)5SH]
 exhibited anti-proliferative properties towards the cancer 
cells, as deduced from the full IC50 analysis (Figure 4.10)  although the 
established IC50 value is relatively high at around 66 M. Nonetheless, it is 
believed that these metal hydrosulfides would have minimal undesirable effect 
on the cells during the duration of H2S release in the cell based on our 
preliminary data. More importantly, the effect of the product as exemplified 
by Mo(CO)5(MeOH) on MCF-10A normal cells was also tested and found to 
be non-toxic over the concentration range and conditions (Figure 4.9).  
 
Figure 4.9 Viability of mammary epithelial cells MCF-10A after 24 h 
incubation with Na[Mo(CO)5SH] (black) and [Mo(CO)5(MeOH)] (blue) as 
determined by the MTS assay.Cell viabilities have been normalized with 























Figure 4.10 Dose-response curves for Na[Mo(CO)5SH] on the MDA-MB-231 
cell line. 
 
In conclusion, a class of Group 6 metal hydrosulfides that is capable of 
releasing hydrogen sulfide gas in a controlled manner has been synthesized 
and characterized. These complexes are stable in the solid state, are water-
soluble, and do not exhibit cytotoxicity towards mammary epithelial cells. In 
addition, they do not release their CO ligands under the conditions employed 
for the release of H2S. These complexes can indeed serve as selective 
hydrogen- sulfide releasing molecules. Infrared, UV-vis and pH measurements 
were employed to monitor the hydrogen sulfide release and all three methods 
placed the rates of H2S release in the order Cr > Mo > W. This trend is 
consistent with the stability of the metal hydrosulfides with respect to the M-S 
bond strength. The more diffused d orbitals of the tungsten atom is better able 
to overlap with the hydrosulfide HOMO and hence a stronger interaction as 
compared to the smaller spatial extent of the chromium d orbitals. 
Na[Mo(CO)5SH]





















4.3 Conclusions  
In this chapter, we have discussed the preparation and characterisation of a 
several transition metal carbonyl complexes which function as 
gasotransmitters releasing agents. These complexes have been found to be 
stable, water-soluble, do not exhibit cytotoxicity and can release their 
respective gasotransmitters in a controlled manner. These are some of the 
more important criteria expected of a gasotransmitter releasing agent. For the 
case of the H2S releasing molecules, it was found that the CO ligands do not 
dissociate under the experimental conditions, hence conferring some 
selectivity character to the metal complex. The quantification studies utilize a 
simple method based on infrared spectroscopy to measure the concentration of 
gases release hence circumventing the need for expensive instruments and 
elaborate setups. pH and UV-vis measurements were also employed in the 
case of the H2S releasing studies to monitor the hydrogen sulfide release and 
both methods, along with the infrared data, placed the rates of H2S release in 
the order Cr > Mo > W. 
4.4 Experimental 
4.4.1 Materials 
Iron dodecarbonyl (95%) was purchased from Strem Chemicals. Deuterated 
chloroform (99.8%), stabilised with 0.5 wt% Ag, 0.03% TMS was purchased 
from Cambridge Isotope Laboratories. 3-mercaptopropionic acid (99%), 
sodium carbonate, ethanol, toluene, sodium hydrosulfide (99%), acetone, 
methanol and N,N-dimethylformamide were purchased from Sigma Aldrich. 
Group 6 metal carbonyls (98%) were purchased from Alfa Aesar. All solvents 





4.4.2 Instrumentation and General Methods 
All manipulations for chemical synthesis were carried out using standard 
Schlenk techniques under a nitrogen atmosphere. Photochemical experiments 
were conducted with a Legrand broadband lamp (350 – 800nm, 11W). All IR 
spectra were obtained with Shimadzu IR Prestige - 21 Fourier – transformed 
infrared spectrometer (1000 – 4000 cm-1, 1 cm-1 resolution, 16 scans co–added 
for spectra averaging) using a 0.05 mm path – length CaF2 cell for liquid 
samples, and a 15 cm path – length CaF2 gas cell for gas samples. The IR 
instrument was calibrated using standard CO gas from a CO cylinder prior to 
measurement. The IR instrument was calibrated using a H2S generated from a 
known quantity of NaSH upon acidification. 1H NMR spectra were recorded 
in CDCl3, unless otherwise stated, on Bruker AC300 Fourier–transformed 
spectrometers operating at 300 MHz at room temperature. All UV-vis 
absorption spectra were obtained with a Shimadzu UV-2550 
spectrophotometer. Electrospray ionisation (ESI) was conducted using a 
Finnigan MAT LCQ spectrometer.  
4.4.3 Solid State Structural Determination 
Single crystal X-ray structural studies were performed on Bruker-AXS Smart 
Apex CCD Single-Crystal Diffractometers by CMMAC, National University 
of Singapore. Data were collected at 100(2) K using graphite-monochromated 
Mo Kα radiation (λ = 0.71073 Å). Data collection was evaluated using 
SMART CCD system and processed for Lorentz and polarisation effects using 
SAINT software and for absorption effects using SADABS software. 





suite of programs. The structure was solved by direct methods. All H atoms 
were put at calculated positions using the riding model. 
4.4.4 Preparation of 1 and 1·Na  
1 molar equivalent of Fe3(CO)12 and 3 molar equivalents of 3-
mercaptopropionic acid were dissolved in toluene and refluxed under N2 
atmosphere until a colour change from green to orange was observed. The 
excess MPA and toluene were removed by distillation leaving behind an 
orange solid. The solid was purified by recrystallization in toluene. Single 
crystals of 1 suitable for X-ray crystallography were obtained by slow 
vaporisation of toluene. Yield: 47%.  IR (toluene, max, cm−1): 2073, 2037, 
1997. ESI-MS (+ve mode): m/z = 480.4 [M+], m/z = 452 [M-CO]+. 1H NMR 
(C6D6, ppm): 2.04-2.08, (t, J = 6.2 Hz, 2H, CH2S), 2.15-2.20 (t, J = 7.3 Hz 2H, 
CH2COOH). 
An aqueous solution containing Na2CO3 was added to a toluene solution 
containing 1. The toluene layer became light yellow. The aqueous layer turned 
orange, indicating the formation of 1·Na. 1H NMR (D2O, ppm): 2.57-2.62, (t, 
J = 7.0 Hz, 2H, CH2S), 2.89-2.94 (t, J = 7.0 Hz, 2H, CH2COO
-). 
4.4.5 CO Quantification  
The quantification of CO present can be determined from its CO rovibrational 
line strength. As tabulated by Medvecz [234], the equation used is as follow: 
𝐴𝑡(𝑣) =
𝑆(𝑚) ∙ 𝐶 ∙ 𝐿






where At(ν) is the experimental absorbance, S(m) is the line strength (cm−2 
atm−1), C is the concentration (atm), L is the path length (cm), and γ(m) is the 
half-width of the line (cm−1). 
A sample of 2.0 mg of 1·Na in 0.5mL deaerated water was subjected to visible 
light irradiation at room temperature for one hour at a fixed distance (10 cm). 
The reaction flask was equipped with a 15 cm long gas cell connected to the 
headspace above the aqueous solution. The FTIR spectrum of the fundamental 
band of CO was scanned over 60 minutes. The absorbance values of a few 
rovibrational P and R-branch lines were recorded and an average value 
obtained and converted into CO pressure using the equation. The ideal gas 
equation (PV = nRT where V = volume of the gas cell and headspace) then 
converts the pressure to the number of moles of CO. The experiment was 
repeated using the same compound dissolved in aerated water. Identical data 
was obtained, indicating that oxygen does not interfere with the 
photochemistry to a significant extent. 
4.4.6 Cell Culture and Cytotoxicity Studies 
Experimental culture of the mammary epithelial cells MCF-10A and MDA-
MB-231 were obtained from the American Type Culture Collection (ATCC) 
and cultured in tissue culture dishes (Nunc Inc., Naperville, IL, USA). The 
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, 
Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin/streptomycin (GIBCO Laboratories) at 37C in 5% CO2 
atmosphere. Cell cultures were maintained in an antibiotic-free condition 





obtained from 1st Base. Concentrations ranging from 1 to 40 M of 1·Na was 
used for incubation with the cells for 24 hours. 
4.4.7 Thermal Stability Measurements 
Separate samples of 1 and its sodium salt, 1·Na were dissolved in toluene and 
water respectively. These are then maintained at a temperature of 40C to 
simulate a physiological temperature for 24 hours under atmospheric 
conditions in the dark to determine their thermal stability in solution. The 
samples were then analysed via IR and NMR respectively after a day. The 
spectroscopic data obtained indicates no appreciable degree of degradation 
compared to that for the pure sample. 
4.4.8 Preparation of [M(CO)5(SH)]- (M = Cr, W) 
1 molar equivalent of Mo(CO)6 and 10 molar equivalents of NaSH were 
dissolved in 2mL of acetone and placed inside a quartz tube. The tube was 
subsequently evacuated by means of a vacuum and then subjected to UV 
photolysis for 3 hours. The crude product was purified by precipitating the 
excess NaSH using a solvent mixture of methanol and diethyl ether (1:5 ratio). 
The volume was subsequently reduced and hexane was added to induce 
precipitation of the yellow Na[Cr(CO)5(SH)]. Yield: 76%. IR (acetone, max, 
cm−1): 2046, 1939, 1887. ESI-MS (-ve mode): m/z = 224.7 [M]- and 196.8 [M-
CO]-. UV (methanol, max, nm): 388. Anal. calcd. for NaCrC5HO5S (%): C 
26.68, S 14.24; found: C 26.59, S 14.21. The same procedure was applied to 
W(CO)6 using the same ratio of starting materials and the orange 
Na[W(CO)5(SH)] was obtained. Yield: 85%. IR (acetone, max, cm−1): 2076, 





(methanol, max, nm): 463. Anal. calcd. for NaWC5HO5S: C 16.82, S 8.98; 
found: C 16.72, S 8.92. 
4.4.9 Preparation of [M(CO)5(SH)]- (M = Mo) 
For the molybdenum derivative, instead of UV irradiation, a 355 nm pulsed 
laser was used for the synthesis. Irradiation of the starting materials in acetone 
for 2 hours formed the brown product. Yield: 79%. IR (acetone, max, cm−1): 
2054, 1943, 1872. ESI-MS (-ve mode): m/z = 270.6 [M]-, m/z = 242.8 [M-
CO]-. UV (methanol, max, nm): 439. Anal. calcd. for NaMoC5HO5S: C 22.32, 
S 11.92; found: C 22.47, S 11.97. 
4.4.10 Measurement of Hydrogen Sulfide Release 
A 5 mM methanol solution of the respective metal hydrosulfide was prepared 
by the addition of the appropriate mass into 10 ml of methanol. This solution 
was then subjected to hydrogen sulfide release by adding in either 10 ml of 
phosphate buffer at pH 6.5 or 4% aqueous HBF4. HBF4 was chosen because 
the anion is non-coordinating and hence would have minimal interference with 
the release. The release of hydrogen sulfide was then monitored directly or 
indirectly by three methods. (a) Infrared spectroscopy (b) UV-vis spectroscopy 
(c) pH measurements 
4.4.11 Infrared Measurements 
A 0.01 M solution of NaSH in deionised water was prepared for calibration 
purposes. The round bottom flask was then attached to a 15 cm long gas cell 
connected to the headspace above the solution. 15 mL of 1 M hydrochloric 
acid was then added and the release of H2S was then monitored until there 





curve was then plotted and subsequently used to determine the total gas 
concentration in the hydrolysis of the metal hydrosulfide. A separate solution 
containing 0.5 mM of the respective metal hydrosulfide was then added to an 
equivalent volume of pH 6.5 phosphate buffer. The reaction flask was 
equipped with the same 15 cm long gas cell connected to the headspace above 
the aqueous solution. The FTIR spectrum of the fundamental band of H2S was 
obtained every 5 minutes for a total duration of 40 minutes. The concentration 
every 5 minutes were then calculated from the calibration curve and plotted 
against time. 
4.4.12 UV-vis Measurements 
To a solution containing 0.5 mM of metal hydrosulfide, an initial UV 
spectrum was taken at time t = 0. 0.2 ml of 4% aqueous HBF4 was then added 
to the solution of metal hydrosulfide in a quartz cuvette and an UV spectrum 
was obtained every 5 minutes over a period of 1 hour. The absorbance of the 
metal hydrosulfides starting material were used as an indicator of hydrogen 
sulfide release as the final product bands were too broad to be of any use. 
4.4.13 pH Measurements 
 To a 0.01 M solution containing the metal hydrosulfide, the pH of the initial 
solution was measured using a pH meter. The pH was monitored every 5 
minutes for a total duration of 1 hour 
4.4.14 Cell Culture (H2S) 
Experimental cultures of the mammary epithelial cells MCF-10A and MDA-
MB-231 were obtained from the American Type Culture Collection (ATCC) 





cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, 
Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) 
and 1% penicillin/streptomycin (GIBCO Laboratories) at 37°C under a 5% 
CO2 atmosphere. Cell cultures were maintained in an antibiotic-free condition 
during cell growth and experiments. Phosphate buffered saline (PBS) was 
obtained from 1st Base.  
4.4.15 Evaluation of Cytotoxicity and Anti-Proliferative Properties 
Approximately 10,000 cells per well were seeded in a 96-well plate and 
allowed to adhere for approximately 24 hours at 37C. 40 M of 
Na[Mo(CO)5SH] and Mo(CO)5(MeOH) in DMSO was separately prepared 
and serially diluted using DMEM media to obtain concentrations of 20 M, 10 
M, 5 M and 1 M. 100 L of each concentrations were then added to the 
cells in triplicates and incubated at 37C and 5% CO2 for 24 hours. The final 
concentration of DMSO in the medium was 0.1% (v/v). 
4.4.16 MTT Proliferation Assay 
The anti-proliferation activity of Na[Mo(CO)5SH] and Mo(CO)5(MeOH) were 
then determined using the MTT assay. Following treatment, the media was 
removed and each well washed with 100 L of PBS, followed by 100 L of 
MTT, (0.5mg/mL) in media and incubated for an additional 2 hours. After the 
incubation period, the MTT was removed and 100 L of DMSO was added to 
dissolve the formazan crystals. The absorbance intensities at 470 nm were then 
measured and cell viabilities relative to the control (DMSO) were calculated. 
In the case for the treatment of Na[Mo(CO)5SH] on MDA-MB-231 cell line, 





growth of 50% of the cell population were determined using Graphpad Prism 
version 5.0 by fitting the values on a dose-response curve (Cell viability vs log 
drug concentration). The experiments were performed in triplicates for each 











Chapter 5 Transition Metal Carbonyls as 
Thiol and Hydrazine Sensors 




5.1 Introduction  
Organometallic radicals have found many important uses such as in 
polymerisation, light-driven processes and heterogeneous catalysis [240-244]. 
Previously it has been reported that a class of stable manganese-based radicals 
containing either N or S ligands has been synthesized [245, 246]. Notably, the 
colours of the radical complex were highly dependent on the type of ligand. 
While S ligands produce a red colouration, a deep blue-green colouration was 
observed with N ligands. These new class of radicals were found to be stable 





properties are thus exploited and used successfully in the detection of 
biological thiols and hydrazines. 
Thiols are biologically important molecules which regulate a variety of 
biological process in an organism. Of particular importance are those that are 
involved in maintaining redox homeostasis such as glutathione (GSH), 
cysteine (Cys) and homocysteine (HCys). In addition to maintaining redox 
balance, thiols are also known to play a functional role in enzymes catalytic 
sites and metabolic pathways [104]. Indeed, research has suggested that thiols 
levels, especially that of homocysteine, are linked to a number of diseases 
including Alzheimer’s, cancer and cardiovascular diseases [105, 107, 247]. 
Plasma thiol concentrations have also been linked to the oxidative stress levels 
associated with the development of some of these conditions [108-111]. 
In view of the biological importance of thiols, it is not surprising that there 
already exist some analytical methodologies for the detection and 
quantification of thiols. While instrumentation techniques are well established, 
fluorescence and optical techniques presents a more viable and attractive 
option for the detection of thiols as shown by the effort devoted to the 
development of optical and fluorescent sensors for thiols over the last decade 
[121, 122]. Such optical and fluorescent probes have the advantage of 
sensitivity, simplicity and most importantly, potential for in vivo bioimaging 
which is becoming increasingly important in the field of biomedical science 
[123-125]. These optical probes function via a variety of reaction mechanisms 
ranging from Michael additions [126, 127], cyclization with aldehydes [128, 
129], cleavages of sulfonamides and sulfonate esters [130, 132, 135], cleavage 





[136-138], cleavage of disulfide bonds [139-141] to the use of nanoparticles 
[146, 248]. 
 
Scheme 5.1 Structure of the three most common biological thiols 
Another class of compounds of detection interest are the hydrazines. 
Hydrazines are a source of pollution globally and can seriously affect human 
health. It is an explosive fuel that is widely used in missile propulsion systems 
[148, 249] and being a strong base, it is often found as a key reactant in the 
synthesis of dyes, pesticides, chemicals and pharmaceuticals [147, 151]. The 
widespread use of hydrazines can potentially degrade the environment should 
its transportation, production and use not be carefully regulated and monitored. 
Existing techniques rely on expensive instrumentation such as HPLC [250], 
GC [251] and capillary electrophoresis [252] which can be cumbersome to be 
employed for use in the field. Hence it is desirable that a simple and rapid 
sensor be developed for the detection of hydrazines.  
The probe we are using contains a cyclopentadienyl manganese carbonyl 
(CpMn(CO)2) scaffold. The unique properties of this probe is that it exhibits 





and being a radical itself can serve as a dual probe in infrared and fluorescent 
imaging studies in chemical biology, especially in radical-rich environments 
involving reactive nitrogen (RNS) and oxygen (ROS) species such as those 
found in active cancer cells. 
This radical complex was originally synthesized in the hope that in the 
presence of a fluorophore, the fluorescence would change significantly to 
allow us to use the radical for bioimaging purposes. However, for reasons that 
would be discussed in Section 5.2.1, the complex was not used for 
fluorescence works but rather adapted for use as a thiol and hydrazine sensor. 
5.2 Results and Discussion 
5.2.1 Fluorescence Studies with CpMn(CO)2(2-aminoanthracene) 
The titled radical complex was prepared via CpMn(CO)3. The 355 nm UC-
laser photolysis of CpMn(CO)3 in THF generates the red CpMn(CO)2(THF) 
complex which then reacts with 2-aminoanthracene to form the orange 
CpMn(CO)2(2-aminoanthracene) complex. Exposure to air or addition of 
H2O2 turns the solution a deep green, signifying the formation of the 
CpMn(CO)2(2-aminoanthracenyl) radical (Figure 5.1). The IR frequencies are 
very similar to previously-reported CpMn(CO)2(ArNH) (Ar = arene) radical 
analogues [253, 254]. The green radical complex can be purified by passing 
the reaction mixture through a silica column using ethyl acetate as the eluant. 
By monitoring its CO bands in the IR spectrum, we found that CpMn(CO)2(2-
aminoanthracenyl) radical is remarkably air-stable in THF at room 





and non-polar solvents such as DMSO, ethanol, acetone, diethyl ether and 
dichloromethane.  
 
Figure 5.1 IR absorption spectra of various CpMn(CO)2 species in THF. (a) 
CpMn(CO)2(2-aminoanthracene), (b) CpMn(CO) (2-aminoanthracenyl) 
radical and (c) CpMn(CO)3. Red: before O2 exposure, Black: after O2 
exposure. 
 
The ESR spectrum of CpMn(CO)2(2-aminoanthracenyl) radical in THF 
(Figure 5.2) shows a sextet of lines with a g-factor centered at 2.005 ± 0.003 
and coupling constants a(55Mn) of 9.45 ± 0.30mT. The data are consistent with 
the spin being more localized on the Mn center (nuclear spin IMn = 5/2), which 
is previously observed for CpMn(CO)2(anilinyl) analogues [255].  
Two other sets of lines were recorded in the ESR spectrum. We believe that 
they correspond to decomposition products such as the manganese oxides, 





























Figure 5.2 ESR spectrum of the CpMn(CO)2 radical. (a) CpMn(CO)2(2-
aminoanthracenyl) radical in THF. The minor peaks (b) are assigned to MnO 
and MnO2. 
 
The UV-vis spectrum recorded for CpMn(CO)2(2-aminoanthracenyl) in THF 
shows that the vibronic features of 2-aminoanthracene between 300 to 450 nm 
are retained even upon coordination to the metal (Figure 5.3). A broad 
emission band (max at 480 nm) obtained for CpMn(CO)2(2-aminoanthracenyl) 
upon 350 nm excitation, also resembles that of free 2-aminoanthracene. From 
time-resolved spectroscopy (Fig. 3), similar fluorescence t1/2 of 6.4 ns and 7.6 
ns have been recorded for CpMn(CO)2(2-aminoanthracenyl) and 2-
aminoanthracene in THF respectively. The quantum yield determined for the 
Mn-centered radical is 0.6, which is essentially the same as the corresponding 
value for free 2-aminoanthracene. The similarity in the spectral properties 
suggests that the CpMn(CO)2 moiety couples weakly with the anthracene 
fluorophore and hence enables equally high quantum yield to be exhibited by 
CpMn(CO)2(2-aminoanthracenyl) as well. 
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Figure 5.3 UV-vis absorption spectra of CpMn(CO)2(2-aminoanthracenyl) 
radical (black) and  2-aminoanthracene (red)  in THF 
 
Figure 5.4 Time-resolved emission (λ
exc 
= 350 nm) spectra of CpMn(CO)2(2-




































5.2.2 Sensing of Thiols 
The metal complex is easily made by a modification of a previously reported 
method [254]. Briefly, a diglyme solution of cyclopentadienyl manganese 
tricarbonyl (CpMn(CO)3) was irradiated with an equimolar volume of aniline. 
The resulting orange carbonyl complex after photolysis is rapidly oxidized 
when exposed to air, forming an intense blue-green solution containing the 
metal radical probe. The reaction scheme is outlined in Figure 5.5. 
 
Figure 5.5 Reaction scheme for the synthesis of the radical probe, 1 and 2 
 
The sensitivity of 1 towards aliphatic thiols is first evaluated. The UV-vis 
spectrum (Figure 5.6) shows a broad absorption in the visible region with max 
centered at 672 nm. This absorption has previously been described as a ligand-
to-metal charge transfer (LMCT) transition from the anilinyl ring onto the Mn 
center [245]. The addition of an aliphatic thiol rapidly turns the solution dark 
red and produces a new absorption peak at 510 nm due to the formation of the 
CpMn(CO)2(-SR) radical complex[246]. As the reaction progresses, a near 
isosbestic point at approximately 555 nm is observed indicating the clean 
conversion of 1 to the red complex. The visual colour changes are displayed in 






Figure 5.6 Changes in UV-vis spectrum upon addition of 0.50 mM of 1-
octanethiol to 0.80 mM of 1 in diglyme monitored over 20 minutes at 1-
minute interval.The black line represents the initial absorbance of 1. 
The detection of biological thiols such as cysteine, homocysteine and 
glutathione is also attempted by adding a drop of the blue diglyme solution 
containing 1 into an aqueous solution containing the thiol. As diglyme and 
water are miscible, a resultant homogeneous red solution is observed for both 
cysteine and homocysteine (Figure 5.7, a–d). However, there is no colour 
change associated with glutathione, which could be a result of steric bulk 
hindering the formation of the thiol complex and subsequently, the radical 
(Figure 5.7, a–e). Nevertheless the negative result may be useful for 
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Figure 5.7 Colour changes to the CpMn(CO)2(anilinyl) radical 1 (0.50 mM) 
observed upon addition of 0.5 mM of the molecule to be detected. (a) 1 only 
(b) 1-octanethiol (c) p-thiocresol (d) cysteine (e) glutathione (f) 
phenylhydrazine. 
  
Figure 5.8 Colour change of 1 (vial 1) when exposed to vapours diffusing out 
of vial 2 containing 1-octanethiol. The purple colouration observed is the 
result of a colour combination of the red CpMn(CO)2(SR) radical and the blue 
complex 1. 
 
The addition of an aromatic thiol, p-thiocresol, to a solution containing 1 
produces a darker blue coloration (Figure 5.7c). If the thiol concentration is 
very low, it becomes difficult to ascertain whether a reaction has indeed taken 
place due to the same shade of blue being produced. In this case, we have used 
1-octanethiol radical probe 






the lighter blue radical complex 2 as the sensor so that the difference in the 
colours is more pronounced. Compared to 1, the max of the absorption of 
complex 2 is red-shifted to 714 nm. Upon the addition of p-thiocresol, the UV-
vis spectrum rapidly changes and shows the appearance of two peaks at 614 
nm and 480 nm which are assigned to CpMn(CO)2(-SC6H4CH3), in agreement 
with previously published data [246]. An isosbestic point is also observed 
close to 600 nm indicating the clean conversion of 2 to CpMn(CO)2(-
SC6H4CH3)  (Figure 5.5). 
 
Figure 5.9 Changes in UV-vis spectrum upon addition of 0.20 mM of p-
thiocresol to 0.50 mM of 2 in diglyme monitored over 10 minutes at 1-minute 
interval. The black line represents the initial absorbance of 2.  
 
5.2.3 Sensing of Hydrazines 
Both 1 and 2 do not respond to the presence of aliphatic amines. However a 
test with hydrazine or phenylhydrazine gives a colour change from blue to 























amines (Figure 5.7f). Similar to the thiol case, an isosbestic point is observed 
near 550 nm in the UV-vis absorption spectrum showing a clean conversion of 
1 to the CpMn(CO)2(NHNHPh) radical complex which absorbs at max = 498 
nm (Figure 5.10). 
 
Figure 5.10 Changes in UV-vis spectrum upon addition of 0.35 mM of 
phenylhydrazine to 0.30 mM of 1 in diglyme monitored over 2 hours at 5-
minute interval. The black line represents the initial absorbance of 1. 
5.2.4 Determination of Limits of Detection 
The detection limit of 1 or 2 towards thiol detection is then assessed via visual 
inspection and UV-vis absorption spectroscopy. We have found that it is 
possible to observe the colour change from blue to red with the addition of 
only 0.1 mM (~15 ppm) of 1-octanethiol, with 1 in a slight excess. 
Furthermore, a solution of 1 changes colour when exposed to the vapour 
emitted by a solution of 1-octanethiol (Figure 5.8). Thus 1 can even be 


















max = 672 nm 





determination of the detection limit has been carried out where the spectral 
absorbances of the generated radical complexes are measured (Figure 5.11).  
 
Figure 5.11 Absorbance vs concentration plot for 1-octanethiol (green), p-
thiocresol (blue) and phenylhydrazine (orange). 1 is used for 1-octanethiol and 
phenylhydrazine sensing while 2 is used for p-thiocresol sensing. UV 
measurements were made under room temperature conditions using varying 
concentrations of the analyte. 
 
The detection limits for 1-octanethiol, p-thiocresol (an aromatic thiol) and 
phenylhydrazine, have been determined to be 3.0 ppm, 2.9 ppm and 3.4 ppm 
respectively (Figure 5.11). As the absorption band of the complex is broad, 
the value chosen for estimation of the detection limits cannot be too low as it 
will introduce a small background contributed by the tailing end of the 
absorption band. Hence, a value of 0.05 absorbance units was chosen to 
maintain a good signal to noise ratio as well as to minimize signal contribution 
























5.2.5 Computational Analysis of 1 with Thiols and Hydrazines 
Although related radical complexes of 1 and 2 have been prepared and 
structurally characterised, their reactivities towards organic molecules have 
not been investigated before [245, 246]. Using the reaction of 1 with a thiol as 
an example (Scheme 5.2), we believe that the first step of the reaction is a 
hydrogen atom (of the S-H bond) abstraction by 1. This regenerates the N-H 
bond of the aniline ligand which is subsequently displaced by the incoming 
thio radical. For the reaction to proceed spontaneously, the S-H bond has to be 
weaker than the aniline N-H bond. Similarly, the differences in the reactivity 
of 1 with other molecules can be traced mainly to the difference in the strength 
of the N-H bond of aniline and the corresponding bond of the other molecule. 
 
Scheme 5.2 The displacement of the anilinyl moiety of 1 with a thiol. 
In order to better understand how 1 and 2 are able to sense thiols and 
hydrazines through reactions, the enthalpy and free energy changes of these 
reactions have been computed using density functional method in Table 5.1 
courtesy of Associate Professor Fan Wai Yip. To reduce computational time, 
the aliphatic thiol, aromatic thiol and hydrazine molecules are represented by 
their simplest members which are methanethiol, benzenethiol and hydrazine. 
Complex 1 is used to represent the sensor. To reduce computation time, the 
molecular structures are first optimized using the  smaller basis set at 
b3lyp/lanl2dz level before single-point energy calculations are carried out 
using a larger basis set 6-311+g(d,p) in the Gaussian 09 suite of programs. The 





subsequent calculations were only based on a single optimized structure. More 
importantly, as we are only interested in the trend rather than absolute values 
of the thermodynamic parameters, the use of two different basis sets would 
have little implications on the eventual conclusion. 
Table 5.1 Enthalpies and free energies of reactions. The values are calculated 
using b3lyp/lanl2dz (structure optimization) followed by b3lyp/6-311+g** 






[Mn]-NHPh + CH3SH → [Mn]-SCH3 + NH2Ph -73.2 -78.2 
[Mn]-NHPh + N2H4 → [Mn]-NHNH2 + NH2Ph -21.7 -30.6 
[Mn]-NHPh + PhSH → [Mn]-SPh + NH2Ph -73.1 -72.2 
 
Table 5.1 shows that the three substitution reactions have been calculated to 
be exothermic and exergonic as well, with the thiol reactions more 
spontaneous than the hydrazine counterpart. The aliphatic and aromatic S-H 
and hydrazine N-H bond energies are indeed low enough for 1 to act as a thiol 
and hydrazine sensor. The calculations are also in agreement with typical 
experimental dissociation energies (BDE) of the X-H bond (where X = S or N) 
which are in the order; aromatic N-H 380 kJmol-1 > aliphatic S-H 350 kJmol-1 > 
aromatic S-H 345 kJmol-1 > hydrazine N-H 303 kJmol-1 [151]. However, 
attempts at locating the transition state of the reaction are unsuccessful; hence 
we are unable to obtain values for the activation barriers. 
5.3 Conclusion 
In conclusion, a dark blue cyclopentadienyl manganese dicarbonyl anilinyl 





and hydrazine sensor with sensitivity limits approaching 3 ppm. This complex 
is stable and easily prepared and can distinguish between the amino acid 
cysteine and the tripeptide glutathione, both biological thiols present in 
mammals. It has also be demonstrated that the probe can also be used to 
distinguish between hydrazine and amines, which is important considering that 
hydrazine are ubiquitous in our environment and is considered a toxic air 
pollutant. The measurements for the limits of detection for the thiols and 
hydrazine have been made via UV-vis spectroscopy and have shown to be in 
the low ppm region, suggesting that this probe is highly sensitive towards the 
presence of the respective analytes. 
5.4 Experimental  
5.4.1 Materials 
Cyclopentadienyl manganese tricarbonyl (CpMn(CO)3, 98%) was purchased 
from Alfa Aesar. 1-octanethiol, p-thiocresol, glycine, phenylhydrazine, aniline, 
3,4,5-trimethoxyaniline, homocysteine, cysteine, reduced glutathione were 
purchased from Sigma Aldrich. Diethylene glycol dimethyl ether (diglyme) 
was purchased from Merck. All solvents and reagents were used without 
further purification.  
5.4.2 Instrumentation and Methods  
Photochemical experiments were conducted with Nd-YAG pulsed laser 
system (Quantel Brilliant B, 10ns pulse, 355 nm). All infrared (IR) absorption 
spectra were obtained on a Shimadzu IR Prestige-21 spectrometer, using a 0.1 
mm path length CaF2 cell for liquid samples. UV-vis absorption spectroscopy 





path length quartz cell. Fluorescence spectroscopy was carried out with a 
Perkin Elmer LS-55 Luminescence Spectrometer while time-resolved 
fluorescence spectroscopy was carried out with a Horiba Jobin Yvon 
Fluorolog spectrometer. Continuous wave X-band ESR spectra in THF were 
obtained in a silica flat cell with a Bruker ELEXSYS E500 spectrometer using 
a variable-temperature Bruker liquid nitrogen cryostat. 
5.4.3 Preparation of CpMn(CO)2(2-aminoanthracenyl) radical 
1 mole equivalent of CpMn(CO)3 was dissolved in 2 ml of THF and irradiated 
at 355 nm for 10 minutes, affording a red solution. 3 mole equivalent of 2-
aminoanthracene was then added, and the solution turned orange-yellow. The 
solution was either exposed to air or treated with 30% H2O2 (1 ml) and its 
colour gradually became green. The reaction mixture was further purified with 
column chromatography with silica as the stationary phase and ethyl acetate as 
the mobile phase. The green solid was collected and dried in air. IR (THF, 
max, cm-1): 1892, 1940. Anal. calcd. for C21H16MnNO2: (%): C 68.30, H 
4.37, N 3.79, Mn 14.88; found: C 69.8, H 7.0, N 3.5, Mn 12.8. 
5.4.4 Preparation of CpMn(CO)2(NHR) radicals (R=C6H5 (1) and 
C6H2(OMe)3 (2)) 
All reactions were carried out using standard vacuum line and Schlenk 
techniques unless otherwise stated. 15 mg of CpMn(CO)3 was dissolved in 4 
ml of diglyme. Two molar equivalent of PhNH2 (aniline) was then added 
before the flask was evacuated. The reaction mixture was then subjected to 
laser photolysis at 355 nm for 120 minutes upon which an orange solution of 





Oxidation of the complex to the CpMn(CO)2(NHPh) was performed by 
breaking the vacuum and allowing passage of air into the flask. A colour 
change from the orange to an intense dark blue solution was immediately 
observed. IR (diglyme, max, cm−1): 1959, 1904. The same method was applied 
to the preparation of the CpMn(CO)2(trimethoxyanilinyl) radical. IR (diglyme, 
max, cm−1): 1949, 1894.  
5.4.5 Stability Studies of 1 and 2 
Stability of the radical was determined by monitoring the UV-vis spectrum 
over 5 days under atmospheric conditions. Briefly, a 0.1 mM solution of both 
sensors was prepared in diglyme and placed in an isolated fume cabinet not 
used for the handling of thiols and hydrazines. Their respective UV-spectrum 
was then obtained at the same time of the day over a period of 7 days. No 
significant changes to the colour or their UV-spectrum were observed. 
5.4.6 UV-vis Absorption Measurements 
An initial UV-vis absorption spectrum was recorded for a solution containing 
0.80 mM of 1 in 4 ml of diglyme. Following that, 0.50 mM of 1-octanethiol 
was added and the solution was thoroughly mixed before recording the change 
in the spectrum. Subsequent measurements were taken at 1-minute interval for 
20 minutes. The time period was chosen such that the final spectrum showed 
very little or no change in the band intensities. A similar procedure was 
repeated to acquire the UV-vis spectrum in the case of p-thiocresol with 
complex 2 and phenylhydrazine with complex 1 over the appropriate time 
interval and period. For the detection of water soluble thiols and hydrazines 





respective analyte was prepared and subjected to detection by the sensor. In all 
cases, the detection was performed under atmospheric conditions using the 
same concentration of complex 1 or 2. Even though the kinetics of detection 
varies among the different analytes, the detection limit does not depend on the 
reaction time because the final product is stable for more than 24 hours to 
allow detection via UV-vis spectrophotometry. 
5.4.7 Sensitivity Limit Calibration  
Differing concentrations (0.1 mM to 0.5 mM) of 1-octanethiol in 5 cm3 of 
diglyme were prepared in separate flasks. A 0.5 cm3 diglyme solution 
containing complex 1 was then added to each flask such that the thiol was 
reacted completely. Only a slight excess of 1 was used in each case in order to 
minimize background contribution from the absorbance of 1 itself.  The UV-
vis spectrum of the product was then recorded to detect and measure the 
CpMn(CO)2(SR) peak absorbance at 510nm. A graph showing the absorbance 
vs thiol concentration was plotted, as shown in Figure 5. The same procedure 
was carried out to obtain the calibration plots for phenylhydrazine and p-
thiocresol. Calculations of the detection limit were performed as follow: First, 
the equation for the calibration curve was obtained via linear regression. The 
equation is then equated to a y-value of 0.02 as the detection limit. From there, 
solving the equation for x gives the minimum concentration of the analyte that 
can be detected. The concentration is then converted to units of ppm. For p-
thiocresol, complex 2 was used as the colorimetric sensor. An example of the 
calculation is shown below. 
For phenylhydrazine, the equation of the curve obtained is y = 1.6132x where 





of y = 0.05 is chosen because this minimizes contributions from the 
background as well as any residual absorbance presented from the sensor itself. 
Thus, the calculations for determining the limit of detection is done by setting 
y = 0.05 in the above equation. Therefore,  
0.05 = 1.6132x  
Solving for x yields x = 0.03099 mM. 
The molar mass of phenylhydrazine is 108.14 g mol-1. 
Mass of phenylhydrazine in 1 dm3 = 0.03099⁡×⁡10-3⁡×⁡108.14⁡=⁡3.35⁡×⁡10-3 g 
We define the unit of ppm as 1 mg of solute in 1 liter of solution; therefore the 
detection limit for phenylhydrazine is thus 3.35 ppm ≈ 3.4ppm. 
The same method is used to calculate the detection limit for 1-octanethiol and 
p-thiocresol. 
5.4.8 Real Time Monitoring 
A vial of 0.1 mL 1-octanethiol to simulate the presence atmospheric thiols is 
placed at an arbitrary distance of 1.5 meter away from another vial containing 
0.1 mM of sensor 1. The time taken for the sensor to change colour is 












Chapter 6 Conclusions and Future Work 
 
Conclusions and Future Work 
 
 
In conclusion, we have demonstrated that organometallic complexes can be 
used in the field of anti-cancer, in thiol sensing, and as CO and H2S releasing 
agents. In the area of anti-cancer drug discovery, a class of iron containing 
cyclopentadienyl complex was found to exhibit low micromolar cytotoxicity 
towards both the breast cancer cell line MDA-MB-231 and cervical cancer cell 
line HeLa. Flow cytometry and confocal microscopy investigations have 
strongly suggested that cell death occurs by apoptosis and not necrosis. The 
complex with the lowest IC50 value, designated as the lead complex, was 
selected for membrane permeability and metabolic stability studies. The 
results were promising as they indicate that the lead complex is highly stable 





This class of cytotoxic iron complexes was then further modified by changing 
a part of the molecule one at a time to ascertain the effect of the substitution 
on the efficacy of the complex as an anti-cancer drug molecule. Interestingly, 
changing the metal to manganese reduces the cytotoxicity properties of the 
molecule but switching iron to cobalt completely shuts down the anti-
proliferative properties. Modifications to the carbonyl and cyclopentadienyl 
ligands also resulted in the loss of the anti-proliferation property. It is also 
noteworthy that upon changing the metal to manganese, the complexes are no 
longer as selective as the iron based complexes towards normal cell lines. 
Nonetheless, exactly how the iron complexes induce apoptosis while leaving 
normal cells unharmed is still a question to be answered. Even though a 
Fenton type mechanism was postulated, this theory was not verified with ROS 
assays. Further, the manganese complexes have shown to exhibit appreciable 
cytotoxicity but do not possess the selectivity of the iron complexes. Is it 
possible then when both metals are combined in a single complex as part of 
the future work, will it lead to increased selectivity and potency? These are 
some questions that can be answered by further synthetic and biological 
experiments. 
The second area where organometallic carbonyl complexes can be employed 
is in their capabilities as CO and H2S releasing molecules. On their own, 
transition metal carbonyl complexes are well known to release CO upon UV 
irradiation. By modifying the ligands around the metal center, we have 
designed several molecules that can release both CO and H2S separately under 
different conditions. In addition, these complexes are water soluble and do not 





complexes may be appropriate for use in vivo studies.  However, while these 
complexes possess such desirable properties, they are regrettably not as air 
stable as existing H2S and CO releasing molecules. In addition, the 
effectiveness of these compounds as CO and H2S releasing agents has not 
been validated. Nonetheless, as the research on these gasotransmitters is still 
relatively new compared to studies on their nitric oxide counterpart, there exist 
many possibilities for further investigations and studies in the development of 
novel, stable and non-toxic organometallic carbonyl complexes as CO and 
H2S releasing agents.  
Lastly, organometallic carbonyl complexes were then applied to the area of 
thiol sensing. Employing UV-vis techniques for qualitative and quantitative 
measurements, we are able to distinguish between two different naturally 
occurring thiols in a mammalian system – cysteine and glutathione. The 
complex used for the sensing experiments was then subsequently applied in 
the detection of hydrazine. Unfortunately, the probe failed to distinguish 
between aliphatic and aromatic hydrazines but only indicates the presence of 
hydrazines in general. Further studies would be required to fine tune the 
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Appendix B - Dose Response Curves for Complexes 1 – 7 
 
IC50 Plots. Dose response curve for the MDA-MB-231 cell line after separate 






IC50 Plots. Dose response curve for the HeLa cell line after separate 






Appendix C – Confocal images 
 
Confocal images of MDA-MB-231 cells after treatment with the 
respective iron complexes. The cells are stained with Annexin V and PI and 
the relative distributions of the AV+/PI- cells gives an indication of the cell 






Confocal images of HeLa cells after treatment with the respective iron 
complexes. The cells are stained with Annexin V and PI and the relative 
distributions of the AV+/PI- cells gives an indication of the cell viability after 






Appendix D – Flow Cytometry Dot Plots 
 
Flow Data of 3 with MDA-MB-231. Detection of early and late apoptotic 
MDA-MB-231 cells after staining with Annexin V-Alexa Fluor 488 and PI. 
Cells were incubated for 24 h with 0 (control), 5 and 10 μM solutions of 3 
before staining.  
 
Flow Data of 6 with MDA-MB-231. Detection of early and late apoptotic 
MDA-MB-231 cells after staining with Annexin V-Alexa Fluor 488 and PI. 
Cells were incubated for 24 h with 0 (control), 5 and 10 μM solutions of 6 
before staining. 
 
Flow Data of 7 with MDA-MB-231. Detection of early and late apoptotic 
MDA-MB-231 cells after staining with Annexin V-Alexa Fluor 488 and PI. 








Flow Data of 3 with HeLa. Detection of early and late apoptotic HeLa cells 
after staining with Annexin V-Alexa Fluor 488 and PI. Cells were incubated 
for 24 h with 0 (control), 5 and 10 μM solutions of 3 before staining. 
 
Flow Data of 6 with HeLa. Detection of early and late apoptotic HeLa cells 
after staining with Annexin V-Alexa Fluor 488 and PI. Cells were incubated 
for 24 h with 0 (control), 5 and 10 μM solutions of 6 before staining. 
 
Flow Data of 7 with HeLa. Detection of early and late apoptotic HeLa cells 
after staining with Annexin V-Alexa Fluor 488 and PI. Cells were incubated 











Appendix E - Mass Spectrometry Data for M(CO)5SH Complexes 
 
Cr(CO05SH in acetone #89 RT: 1.67 AV: 1 SB: 50 0.47-1.38 NL: 5.02E7
T: - c ESI Full ms [50.00-700.00]























































Mo(CO)5SH in acetone #130 RT: 2.24 AV: 1 SB: 38 2.48-3.12 NL: 4.01E7
T: - c ESI Full ms [50.00-700.00]


























































W #132 RT: 2.39 AV: 1 SB: 16 2.68-2.97 NL: 2.58E7
T: - c ESI Full ms [100.00-800.00]



















































Appendix F – Crystallographic Data 
1. Triphenyl Isothiocyanate 
Identification code  c141 
Empirical formula  C20 H15 N S 
Formula weight  301.39 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 9.1433(11) Å = 90°. 
 b = 17.476(2) Å = 
106.801(2)°. 
 c = 10.1867(13) Å  = 90°. 
Volume 1558.2(3) Å3 
Z 4 
Density (calculated) 1.285 Mg/m3 
Absorption coefficient 0.203 mm-1 
F(000) 632 
Crystal size 0.60 x 0.34 x 0.20 mm3 
Theta range for data collection 2.33 to 27.50°. 
Index ranges -11<=h<=10, -19<=k<=22, -12<=l<=13 
Reflections collected 10898 
Independent reflections 3571 [R(int) = 0.0298] 
Completeness to theta = 27.50° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9605 and 0.8879 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3571 / 0 / 199 
Goodness-of-fit on F2 1.044 
Final R indices [I>2sigma(I)] R1 = 0.0412, wR2 = 0.1114 
R indices (all data) R1 = 0.0491, wR2 = 0.1171 





Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for C141. U(eq) is defined as one third of the trace of 
the orthogonalized Uij tensor. 
___________________________________________________________________________  
 x y z U(eq) 
_______________________________________________________________  
S(1) 2480(1) 405(1) 7611(1) 41(1) 
N(1) 4132(1) 1018(1) 6002(1) 19(1) 
C(1) 4260(2) 1557(1) 4935(1) 16(1) 
C(2) 3435(2) 2298(1) 5107(1) 16(1) 
C(3) 3456(2) 2554(1) 6404(1) 19(1) 
C(4) 2720(2) 3228(1) 6560(1) 22(1) 
C(5) 1974(2) 3654(1) 5420(2) 22(1) 
C(6) 1980(2) 3416(1) 4129(2) 24(1) 
C(7) 2705(2) 2738(1) 3967(1) 21(1) 
C(8) 5968(2) 1696(1) 5143(1) 17(1) 
C(9) 6500(2) 2400(1) 4847(2) 22(1) 
C(10) 8056(2) 2515(1) 5033(2) 28(1) 
C(11) 9082(2) 1927(1) 5513(2) 30(1) 
C(12) 8560(2) 1222(1) 5793(2) 31(1) 
C(13) 7012(2) 1105(1) 5615(2) 24(1) 
C(14) 3468(2) 1157(1) 3566(1) 16(1) 
C(15) 4258(2) 926(1) 2666(1) 21(1) 
C(16) 3495(2) 548(1) 1460(2) 26(1) 
C(17) 1949(2) 405(1) 1146(2) 25(1) 
C(18) 1152(2) 637(1) 2046(2) 26(1) 
C(19) 1907(2) 1004(1) 3250(2) 23(1) 






Table 3. Bond lengths [Å] and angles [°] for C141. 
_____________________________________________________________  
S(1)-C(20)  1.5782(15) 
N(1)-C(20)  1.1708(18) 
N(1)-C(1)  1.4683(17) 
C(1)-C(2)  1.5336(18) 
C(1)-C(8)  1.5332(18) 
C(1)-C(14)  1.5402(18) 
C(2)-C(3)  1.3904(18) 
C(2)-C(7)  1.3917(19) 
C(3)-C(4)  1.3881(19) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.382(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.382(2) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.391(2) 
C(6)-H(6)  0.9500 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.3892(19) 
C(8)-C(13)  1.3940(19) 
C(9)-C(10)  1.394(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.382(2) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.381(2) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.389(2) 
C(12)-H(12)  0.9500 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.3812(19) 
C(14)-C(19)  1.3949(19) 
C(15)-C(16)  1.392(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.379(2) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.387(2) 





C(18)-C(19)  1.380(2) 
C(18)-H(18)  0.9500 











































































Table 4. Anisotropic displacement parameters (Å2 x 103) for C141. The 
anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
_______________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________  
S(1) 28(1)  52(1) 48(1)  29(1) 20(1)  8(1) 
N(1) 20(1)  19(1) 20(1)  2(1) 6(1)  1(1) 
C(1) 17(1)  16(1) 16(1)  1(1) 6(1)  0(1) 
C(2) 13(1)  18(1) 18(1)  -1(1) 5(1)  -1(1) 
C(3) 18(1)  22(1) 17(1)  0(1) 4(1)  -1(1) 
C(4) 23(1)  23(1) 21(1)  -5(1) 9(1)  -1(1) 
C(5) 19(1)  18(1) 29(1)  -4(1) 6(1)  1(1) 
C(6) 24(1)  21(1) 23(1)  1(1) 1(1)  2(1) 
C(7) 24(1)  22(1) 16(1)  -2(1) 4(1)  1(1) 
C(8) 16(1)  21(1) 14(1)  -4(1) 3(1)  -1(1) 
C(9) 22(1)  23(1) 25(1)  -3(1) 9(1)  -1(1) 
C(10) 26(1)  29(1) 32(1)  -9(1) 14(1)  -9(1) 
C(11) 16(1)  45(1) 31(1)  -12(1) 8(1)  -5(1) 
C(12) 19(1)  38(1) 33(1)  -1(1) 4(1)  5(1) 
C(13) 19(1)  26(1) 26(1)  0(1) 4(1)  1(1) 
C(14) 18(1)  14(1) 17(1)  0(1) 4(1)  0(1) 
C(15) 16(1)  23(1) 23(1)  -3(1) 6(1)  -3(1) 
C(16) 22(1)  32(1) 24(1)  -9(1) 10(1)  -3(1) 
C(17) 22(1)  26(1) 23(1)  -8(1) 3(1)  -3(1) 
C(18) 14(1)  29(1) 32(1)  -8(1) 4(1)  -3(1) 
C(19) 18(1)  26(1) 27(1)  -7(1) 9(1)  -2(1) 






Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters 
(Å2x 10 3) for C141. 
_______________________________________________________________ 
 x  y  z  U(eq) 
_______________________________________________________________  
  
H(3) 3980 2266 7191 23 
H(4) 2729 3396 7449 26 
H(5) 1456 4111 5525 27 
H(6) 1487 3716 3349 28 
H(7) 2702 2574 3077 25 
H(9) 5800 2806 4515 27 
H(10) 8411 2999 4830 33 
H(11) 10143 2008 5650 37 
H(12) 9263 815 6109 37 
H(13) 6663 619 5816 29 
H(15) 5322 1025 2871 25 
H(16) 4045 387 847 31 
H(17) 1434 149 319 30 
H(18) 85 543 1834 31 






2. Hexanoyl Isothiocyanate 
Table 1.  Crystal data and structure refinement for C164. 
Identification code  c164 
Empirical formula  C7 H14 N2 O S 
Formula weight  174.26 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 5.001(9) Å = 83.64(3)°. 
 b = 6.898(13) Å = 86.47(3)°. 
 c = 13.48(3) Å  = 85.77(3)°. 
Volume 460.2(15) Å3 
Z 2 
Density (calculated) 1.257 Mg/m3 
Absorption coefficient 0.301 mm-1 
F(000) 188 
Crystal size 0.60 x 0.04 x 0.02 mm3 
Theta range for data collection 2.98 to 25.00°. 
Index ranges -5<=h<=5, -4<=k<=8, -15<=l<=15 
Reflections collected 2557 
Independent reflections 1593 [R(int) = 0.0487] 
Completeness to theta = 25.00° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9940 and 0.8400 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1593 / 0 / 113 
Goodness-of-fit on F2 1.066 
Final R indices [I>2sigma(I)] R1 = 0.0726, wR2 = 0.1580 
R indices (all data) R1 = 0.1188, wR2 = 0.1842 





Table 2.  Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for C164. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
_______________________________________________________________  
 x y z U(eq) 
_______________________________________________________________  
S(1) 7034(3) -2779(2) -141(1) 26(1) 
O(2) 10791(7) -142(5) 2337(3) 29(1) 
C(1) 8681(10) -2036(8) 773(4) 23(1) 
N(1) 10850(9) -2952(7) 1131(4) 28(1) 
N(2) 7720(9) -367(7) 1179(4) 24(1) 
C(3) 8787(11) 515(8) 1911(4) 26(1) 
C(4) 7179(10) 2361(8) 2148(4) 27(1) 
C(5) 8293(10) 3349(8) 2965(4) 26(1) 
C(6) 6524(10) 5130(8) 3223(4) 28(1) 
C(7) 7650(11) 6237(8) 3971(4) 31(1) 






Table 3. Bond lengths [Å] and angles [°] for C164. 
_____________________________________________________________  
S(1)-C(1)  1.669(6) 
O(2)-C(3)  1.219(6) 
C(1)-N(1)  1.306(7) 
C(1)-N(2)  1.372(7) 
N(2)-C(3)  1.369(7) 
C(3)-C(4)  1.510(8) 
C(4)-C(5)  1.511(8) 
C(5)-C(6)  1.520(8) 
C(6)-C(7)  1.490(8) 




















Table 4. Anisotropic displacement parameters (Å2 x 103) for C164.  The 
anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
_______________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________  
S(1) 19(1)  20(1) 39(1)  -12(1) -5(1)  5(1) 
O(2) 22(2)  27(2) 41(2)  -7(2) -10(2)  5(2) 
C(1) 17(3)  21(3) 28(3)  1(2) 5(2)  -2(2) 
N(1) 19(2)  24(3) 41(3)  -16(2) -7(2)  9(2) 
N(2) 18(2)  17(3) 38(3)  -10(2) -5(2)  2(2) 
C(3) 31(3)  18(3) 27(3)  -2(2) 9(3)  1(2) 
C(4) 25(3)  21(3) 34(3)  -10(2) 1(2)  3(2) 
C(5) 23(3)  22(3) 32(3)  -7(2) 1(2)  -3(2) 
C(6) 19(3)  27(3) 37(3)  -5(3) -3(2)  2(2) 
C(7) 33(3)  25(3) 34(3)  -4(3) -3(3)  -2(3) 






Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters 
(Å2x 10 3) for C164. 
_______________________________________________________________  
 x  y  z  U(eq) 
_______________________________________________________________  
  
H(1N) 11850(90) -2430(70) 1640(40) 17(13) 
H(2N) 11500(120) -3920(90) 840(40) 35(18) 
H(1A) 6520(130) 160(100) 870(50) 50(20) 
H(4A) 5314 2041 2353 32 
H(4B) 7116 3291 1534 32 
H(5A) 10113 3753 2746 31 
H(5B) 8453 2404 3571 31 
H(6A) 6247 6017 2604 33 
H(6B) 4747 4702 3487 33 
H(7A) 9417 6678 3704 37 
H(7B) 7947 5345 4588 37 
H(8A) 5715 8954 3646 58 
H(8B) 6666 8595 4768 58 






Table 6. Hydrogen bonds for C164 [Å and °]. 
_______________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
_______________________________________________________________
____________ 
 N(1)-H(1N)...O(2) 0.99(5) 1.95(5) 2.663(7) 127(4) 
 N(1)-H(2N)...S(1)#1 0.85(6) 2.60(7) 3.436(7) 171(5) 
 N(2)-H(1A)...S(1)#2 0.79(7) 2.60(7) 3.362(6) 162(7) 
_______________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  





3. Cyclopentadienyl iron dicarbonyl thiocyanate 
Table 1.  Crystal data and structure refinement for C790. 
Identification code  c790 
Empirical formula  C8 H5 Fe N O2 S 
Formula weight  235.04 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.798(4) Å = 93.169(7)°. 
 b = 7.024(4) Å = 95.036(7)°. 
 c = 10.813(6) Å  = 118.514(7)°. 
Volume 449.1(4) Å3 
Z 2 
Density (calculated) 1.738 Mg/m3 
Absorption coefficient 1.871 mm-1 
F(000) 236 
Crystal size 0.40 x 0.26 x 0.10 mm3 
Theta range for data collection 1.90 to 27.50°. 
Index ranges -8<=h<=8, -9<=k<=9, -14<=l<=14 
Reflections collected 4151 
Independent reflections 2052 [R(int) = 0.0515] 
Completeness to theta = 27.50° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.5570 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2052 / 0 / 118 
Goodness-of-fit on F2 1.065 
Final R indices [I>2sigma(I)] R1 = 0.0533, wR2 = 0.1200 
R indices (all data) R1 = 0.0738, wR2 = 0.1469 





Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for C790. U(eq) is defined as one third of the trace of 
the orthogonalized Uij tensor. 
_______________________________________________________________  
 x y z U(eq) 
_______________________________________________________________  
Fe(1) 5305(1) 2275(1) 2345(1) 10(1) 
S(1) 3906(2) -1262(2) 1484(1) 17(1) 
O(1) 1895(6) 898(6) 4058(3) 23(1) 
O(2) 2515(7) 3033(7) 435(4) 28(1) 
N(1) 3899(8) -3427(8) 3640(4) 23(1) 
C(1) 7645(8) 4815(8) 3658(5) 16(1) 
C(2) 7870(9) 5491(9) 2433(5) 21(1) 
C(3) 8446(8) 4115(9) 1697(5) 17(1) 
C(4) 8586(9) 2631(9) 2479(5) 20(1) 
C(5) 8068(8) 3019(8) 3681(5) 17(1) 
C(6) 3916(8) -2506(8) 2776(5) 15(1) 
C(7) 3219(8) 1435(8) 3394(4) 13(1) 






Table 3. Bond lengths [Å] and angles [°] for  C790. 
_____________________________________________________________  
Fe(1)-C(8)  1.778(5) 
Fe(1)-C(7)  1.789(5) 
Fe(1)-C(2)  2.083(5) 
Fe(1)-C(1)  2.084(5) 
Fe(1)-C(5)  2.096(5) 
Fe(1)-C(3)  2.109(5) 
Fe(1)-C(4)  2.114(5) 
Fe(1)-S(1)  2.2970(18) 
S(1)-C(6)  1.690(5) 
O(1)-C(7)  1.135(6) 
O(2)-C(8)  1.146(6) 
N(1)-C(6)  1.163(7) 
C(1)-C(5)  1.422(7) 
C(1)-C(2)  1.428(7) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.432(8) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.410(7) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.422(7) 
C(4)-H(4)  1.0000 















































































Table 4. Anisotropic displacement parameters (Å2 x 103) for C790. The 
anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
_______________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________  
Fe(1) 10(1)  11(1) 4(1)  1(1) -1(1)  2(1) 
S(1) 23(1)  13(1) 8(1)  -1(1) -1(1)  3(1) 
O(1) 21(2)  33(2) 12(2)  5(2) 8(2)  9(2) 
O(2) 27(2)  47(3) 15(2)  13(2) 0(2)  20(2) 
N(1) 26(3)  24(2) 18(2)  5(2) 2(2)  12(2) 
C(1) 16(3)  11(2) 11(2)  -3(2) 0(2)  0(2) 
C(2) 13(2)  15(3) 24(3)  7(2) -3(2)  -1(2) 
C(3) 9(2)  23(3) 9(2)  3(2) 1(2)  -1(2) 
C(4) 15(3)  26(3) 14(2)  -1(2) 0(2)  6(2) 
C(5) 10(2)  17(3) 17(3)  4(2) -6(2)  2(2) 
C(6) 16(2)  9(2) 16(3)  -2(2) 0(2)  5(2) 
C(7) 16(3)  14(2) 4(2)  -1(2) -3(2)  4(2) 






Table 5. Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3) for C790. 
_______________________________________________________________  
 x  y  z  U(eq) 
_______________________________________________________________  
  
H(1) 7290 5504 4377 19 
H(2) 7692 6735 2145 25 
H(3) 8733 4214 805 20 
H(4) 8953 1459 2221 24 


























4. Cyclopentdienyl iron dicarbonyl isothiocyanate 
Table 1.  Crystal data and structure refinement for C532. 
Identification code  c532 
Empirical formula  C8 H5 Fe N O2 S 
Formula weight  235.04 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/m 
Unit cell dimensions a = 6.3240(10) Å = 90°. 
 b = 8.9082(14) Å = 91.684(4)°. 
 c = 7.8468(12) Å  = 90°. 
Volume 441.86(12) Å3 
Z 2 
Density (calculated) 1.767 Mg/m3 
Absorption coefficient 1.902 mm-1 
F(000) 236 
Crystal size 0.20 x 0.11 x 0.05 mm3 
Theta range for data collection 2.60 to 27.50°. 
Index ranges -7<=h<=8, -11<=k<=11, -9<=l<=10 
Reflections collected 3137 
Independent reflections 1075 [R(int) = 0.0322] 
Completeness to theta = 27.50° 99.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9109 and 0.7022 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1075 / 0 / 67 
Goodness-of-fit on F2 1.236 
Final R indices [I>2sigma(I)] R1 = 0.0310, wR2 = 0.0783 
R indices (all data) R1 = 0.0405, wR2 = 0.1073 





Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for C532. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
_______________________________________________________________  
 x y z U(eq) 
_______________________________________________________________
_________________   
Fe(1) 674(1) 2500 1677(1) 11(1) 
S(1) -3062(2) 2500 -3619(1) 19(1) 
O(1) -1864(3) 26(2) 3000(3) 22(1) 
N(1) -857(5) 2500 -481(4) 16(1) 
C(1) 3507(6) 2500 301(5) 17(1) 
C(2) 3410(4) 1206(3) 1345(4) 17(1) 
C(3) 3288(4) 1702(3) 3076(4) 19(1) 
C(4) -916(4) 996(3) 2500(3) 16(1) 






Table 3. Bond lengths [Å] and angles [°] for C532. 
_____________________________________________________________  
Fe(1)-C(4)  1.806(3) 
Fe(1)-C(4)#1  1.806(3) 
Fe(1)-N(1)  1.925(4) 
Fe(1)-C(3)#1  2.083(3) 
Fe(1)-C(3)  2.083(3) 
Fe(1)-C(2)#1  2.102(3) 
Fe(1)-C(2)  2.102(3) 
Fe(1)-C(1)  2.118(4) 
S(1)-C(5)  1.636(4) 
O(1)-C(4)  1.128(4) 
N(1)-C(5)  1.159(5) 
C(1)-C(2)#1  1.416(4) 
C(1)-C(2)  1.416(4) 
C(2)-C(3)  1.433(4) 















































Symmetry transformations used to generate equivalent atoms:  





Table 4. Anisotropic displacement parameters (Å2 x 103) for C532. The 
anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
_______________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________  
Fe(1) 12(1)  11(1) 11(1)  0 0(1)  0 
S(1) 26(1)  19(1) 13(1)  0 -5(1)  0 
O(1) 23(1)  17(1) 26(1)  1(1) 5(1)  -5(1) 
N(1) 16(2)  16(2) 16(2)  0 0(1)  0 
C(1) 12(2)  19(2) 20(2)  0 4(2)  0 
C(2) 10(1)  17(1) 24(1)  -2(1) 1(1)  2(1) 
C(3) 12(1)  24(2) 19(1)  4(1) -3(1)  1(1) 
C(4) 16(1)  18(1) 14(1)  -2(1) 0(1)  4(1) 






Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters 
(Å2x 10 3) for C532. 
_______________________________________________________________  
 x  y  z  U(eq) 
_______________________________________________________________  
  
H(1) 3596 2500 -969 21 
H(2) 3455 140 948 20 
H(3) 3248 1042 4106 22 
_______________________________________________________________  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
